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MECHANISMS OF COMPLEMENT RESISTANCE BY PATHOGENIC 
NAEGLERIA FOWLERI AMOEBAE. 
ABSTRACT 
A dissertation submitted in partial fulfillment of the requirements for the Degree 
of Doctor of Philosophy at Virginia Commonwealth University. 
Denise Marie Toney 
Virginia Commonwealth University 
Major Director: Dr. Francine Marciano-Cabral 
The genus Naegleria is composed of a distinct group of free-living 
amoeboflagellates that include both pathogenic and nonpathogenic species. N. 
Jowleri, the only pathogenic species of Naegleria to be isolated from humans, is the 
etiological agent of primary amoebic meningoencephalitis, a rare but rapidly fatal 
disease of the central neIVOUS system in humans and in laboratory animals. The 
mechanisms of pathogenicity and the determinants of virulence of N. Jowleri are 
unknown. Both pathogenic and nonpathogenic Naegleria activate the alternative 
complement pathway, however pathogenicN. Jowleri are complement-resistant and 
nonpathogenic N. gruberi are complement-sensitive. The ability to resist 
complement-mediated lysis may be an important determinant of virulence of N. 
Jowleri. These studies demonstrate that pathogenic N. Jowleri possess at least two 
xii 
mechanisms for resisting complement lysis. Pathogenic N. Jowleri synthesize a 
surface associated protein which appears to possess structural as well as functional 
homology to the human complement regulatory glycoprotein, CD59. Also, other 
surface glycoproteins appear to play a role in regulating complement lysis either 
directly or by indirect inhibitory mechanisms. In addition to complement 
regulatory glycoproteins, pathogenic N. Jowleri possess the ability to remove 
membrane deposited complement proteins, C5b-C9, from their cell surface by 
membrane vesiculation. The presence of complement regulatory proteins and the 
ability to vesiculate in response to serum complement, alone or in combination, 
serves to protect pathogenic N. Jowleri from complement-mediated damage. 
Nonpathogenic N. gntberi do not appear to possess surface complement regulatory 
proteins or the ability to vesiculate in response to serum complement. Additional 
studies demonstrate that growth medium modulates complement resistance and 
virulence. More importantly, by using changes in growth medium, an in vitro 
model was developed for differentially expressing proteins associated with the 
complement-resistant state. The induction of these de novo synthesized proteins 
may serve as markers of virulence and complement resistance in pathogenic N. 
Jowleri amoebae. 
Introduction 
Primary amoebic meningoencephalitis 
The genus Naeglena is composed of a distinct group of free-living 
amoeboflagellates that include both pathogenic and nonpathogenic species. 
Naeglena species can be isolated from a variety of environmental sources including 
soil and freshwater habitats [6 1] .  N. Jowlen, the only pathogenic species of 
Naeglena to be isolated from humans, is the etiological agent of primary amoebic 
meningoencephalitis (P AME). P AME is a rare but rapidly fatal disease of the 
central nervous system in humans and in laboratory animals ( 12, 13, 17] .  
Outbreaks of P AME have been reported from Australia, Czechoslovakia, and the 
United States [1 ] .  PAME occurs in healthy children and young adults with a 
recent history of swimming in freshwater lakes and ponds. Infection is initiated by 
the introduction of water containing amoebic trophozoites into the nasal cavity of 
the host. The amoebae gain entry into the brain by penetrating the nasal mucosa 
and the olfactory apparatus. Once in the brain, the amoebae cause extensive 
tissue damage and inflammation. Death occurs in approximately 10- 14 days [ 13, 
43, 66] . The pathogenesis of P AME is poorly understood. Haematogenous spread 
of N. Jowlen has not been observed in human cases and is believed to be due to 
1 
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amoebicidal factors in serum [13]. Mice or guinea pigs infected intranasally 
develop a fatal disease resembling P AME in humans. The mouse model has been 
used extensively to study host resistance to infection by N. fowleri [65, 100]. 
Growth and cultivation 
In the environment, N. fowleri amoebae feed on bacteria and yeast. In the 
laboratory, environmental Naegleria isolates can be adapted to growth on non­
nutrient agar containing Escherichia coli or Enterobacter aerogenes [44]. However, 
axenic culture of Naegleria is necessary for biochemical and molecular studies of 
the amoebae. A number of complex liquid media have been developed for axenic 
cultivation of the amoebae [31, 61]. Pathogenic N. fowleri can be cultured 
axenically in Nelson medium consisting of liver digest, glucose and serum in Page 
amoeba saline [81, 124]. Nonpathogenic N. gruberi cannot be easily cultivated in 
Nelson medium. Instead, Balamuth (H4) medium is used for the cultivation of 
N. gruberi amoebae. Balamuth (H4) medium consists of liver digest, glucose, 
serum, protease peptone, yeast extract and bovine hemin in Page amoeba saline 
[4]. To allow for comparisons, both pathogenic N. fowleri and nonpathogenic N. 
gruberi can be cultivated in Cline medium which consists of a mixture of H4 
medium and Nelson medium [14]. 
Prolonged growth of pathogenic N. fowleri amoebae in axenic culture 
results in attenuation of virulence. Serial passage of N. fowleri through mice 
maintains the virulence of the amoebae [125, 129]. Studies have demonstrated 
that growth medium influences both biochemical and physiological functions of 
3 
Naegleria amoebae. Factors such as growth rate, virulence, susceptibility to 
complement, rate of locomotion, temperature tolerance, drug susceptibility, and 
protein profiles were shown to differ depending on the growth medium in which 
amoebae were maintained [14, 40, 63, 120]. 
Humoral and cell-mediated immunity 
The mechanisms responsible for pathogenicity of N. fowleri are unknown. 
[100]. Mice immunized by repeated administration of formalinized amoebae, 
freeze-thawed amoebic extracts, or sublethal doses of live amoebae develop 
species-specific agglutinating antibodies [29, 100, 117]. Although a marked 
humoral response has been observed in immunized mice, all immunization 
regimens have produced only modest protection against infection by N. fowleri. 
Failure to impair host resistance with immunosuppressive treatments such as 
cyclophosphamide or 6OCo-irradiation indicates that humoral immunity is not a 
major line of host defense against PAME. Newsome and Arnold [83] 
demonstrated that congenitally athymic mice (T cell-deficient) and euthymic mice 
were equally susceptibile to infection by N. fowleri. In addition to these studies, 
an inability to impair host resistance to N. fowleri infection with diethylstilbestrol, 
which depresses delayed-type hypersensitivity, corroborates the suggestion that . 
cell-mediated immunity alone, is not involved in host resistance against N. fowleri 
infections [100]. 
4 
Innate resistance 
Innate resistance factors appear to play a more important role than· 
acquired immunity for host defense against N. Jowleri infection [ 100] . 
Susceptibility to N. Jowleri varies greatly among mouse strains. The most 
susceptible mouse model of P AME is the C5 complement-deficient strain A/HeCr 
[28] . Experimental evidence suggests that complement is an important factor in 
host defense against N. Jowleri since complement-deficient mice or cobra venom 
factor-treated mice are more susceptible to infection by N. Jowleri [28, 100] . The 
pathogenicity of Naegleria amoebae in vivo correlates with resistance to 
complement-mediated lysis in vitro. Both pathogenic and nonpathogenic Naegleria 
amoebae activate the alternative complement pathway however, only 
nonpathogenic amoebae are readily lysed by human complement [39, 125] .  The 
ability of highly-pathogenic N. Jowleri to activate complement and convert 
complement component C5 to C5b suggests that the point of complement 
regulation must occur at the terminal stage of the complement cascade, membrane 
attack complex (MAC) formation [ 126] . The Naeglerial components that activate 
the complement cascade but allow highly-pathogenic N. fowleri to escape 
complement-mediated damage are unknown. Enzymatic removal of surface 
components from amoebae with trypsin or papain, but not sialidase increase the 
susceptibility of complement-resistant amoebae to complement lysis, indicating 
that proteins on the surface of the amoebae play a role in resistance to 
complement lysis [ 126] . However, the inability of protease inhibitors to block 
complement resistance in vitro suggests that a complement-specific protease is not 
5 
involved in resistance of N. Jowleri to complement lysis [ 126] . The ability of 
highly-pathogenic N. Jowleri to escape complement lysis may be an important 
virulence factor in the pathogenesis of P AME. 
The complement system 
The complement system consists of a series of more than 30 soluble and 
membrane bound plasma proteins which interact in a sequential cascade to cause 
irreversible damage to the membranes of cellular targets. [5, 67, 80]. The 
complement cascade can be initiated by both immunological and non­
immunological stimuli and depends on the conversion of serum zymogens to active 
serine esterases. When activated, the complement proteins together have the 
ability to destroy microorganisms including bacteria, viruses, parasites, and tumor 
cells. Complement proteins, also, play a role in eliminating foreign antigens from 
tissues and blood [53] .  In addition to its involvement in anti-microbial immunity, 
the complement system is involved in inflammatory tissue damage seen in a 
variety of diseases [104]. 
The complement system can be initiated by two distinct pathways, the 
classical pathway which is antibody-dependent and the alternative pathway which 
is antibody-independent (Fig 1) .  The presence of two different pathways for 
complement activation allows for augmented host immunity and serves as a bridge 
between the cellular and humoral immune systems. The role of these activation 
pathways is to produce enzymes which activate complement component C3. The 
classical pathway (C1 through C9) is activated by the binding of complement 
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component C1 to immune complexes by virtue of the affinity of the globular heads 
of C1q for the Fc portion of antigen-bound immunoglobulin, specifically IgM, 
IgG 1, IgG2, or IgG3. Once bound to antibody, C1 is capable of proteolytically 
cleaving complement components C4 and C2 resulting in the formation of a 
C4b2a complex termed the C3 convertase, on the cell surface of microorganisms 
[53] .  Activation of the classical complement pathway requires development of 
humoral immunity (antibody) against a target cell or antigen. 
The alternative complement pathway (ACP) occurs in the absence of 
antibody. Instead, the ACP is activated by microbial cell wall constituents such 
as particulate polysaccharides and lipopolysaccharides, or by the spontaneous 
hydrolysis of the intramolecular thioester bond of complement component C3 in 
the fluid phase. Hydrolysis of C3 results in a product which possesses a C3b-like 
conformation, termed C3(H20). The hydrolyzed C3(H20) then interacts with 
Factors B and D resulting in formation of an alternative pathway C3 convertase, 
C3(H20)Bb [25, 53, 74, 79, 80] . 
Although each pathway is initiated by different mechanisms, the C3 
convertases formed by either pathway are homologous and serve to split multiple 
C3 molecules. The association of C3b with the C3 convertase of either pathway 
results in the formation of an enzyme that activates and cleaves complement 
component C5. The products resulting from cleavage of component C5 are C5a 
and C5b [53] .  The generation of C5b serves as the first step in MAC formation. 
The C5b fragment possesses a labile binding site for C6. The C5b6 complex 
remains loosely associated with the cell membrane until component C7 binds. 
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Figure 1: Schematic diagram of the complement cascade. Asterisks denote sites 
controlled by complement regulatory proteins or regulatory mechanisms. 
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The binding of C7 to C5b6 causes a conformational change whereby hydrophobic 
sites are exposed, resulting in the anchoring of the complex to the lipid bilayer [32, 
80] . Membrane deposited C5b67 reacts with C8 and C9 to form a multimolecular 
complex termed the MAC which creates pores within cell membranes [88] . The 
final events of MAC assembly are unfolding and polymerization of complement 
component C9 within the target membrane, which causes weakening of membrane 
structure, formation of transmembrane channels, and subsequent cell lysis. The 
importance of the terminal complement proteins comprising the MAC (C5, C6, 
C7, C8, or C9) is best demonstrated by the fact that individuals with inherited 
deficiencies in the production of these proteins suffer from gram negative bacterial 
infections such as Neisseria meningitidis or Neisseria gono"hoeae [92, 103]. 
Complement pathway regulation 
Complement activation on cell membranes is controlled by both fluid-phase 
and membrane-bound regulators [74]. These regulators act to control normal 
complement activation to prevent complement depletion, and to prevent lysis of 
homologous or "self' blood cells [2] .  The inability of individuals to properly 
regulate the complement pathway results in a number of acquired and inherited 
disorders including hereditary angioedema and paroximal nocturnal· 
hemoglobinuria [20, 37] . However, most individuals are not predisposed to 
diseases of this type due to the ability to synthesize complement regulatory 
proteins. Eukaryotic cells including neutrophils and erythrocytes possess 
complement regulatory proteins which protect them from homologous complement 
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damage. Regulatory proteins include decay accelerating factor (DAF), 
homologous restriction factor (HRF), and CD59, all of which possess glycosyl­
phosphatidylinositol (GPI) membrane anchors [70, 88, 130]. DAF is a membrane­
bound glycoprotein (MW 65-70 kDa) present on virtually all peripheral blood, 
epithelial and endothelial cells which inhibits the amplification enzymes, C3 and 
C5 convertases of the complement cascade [35, 36, 52, 85]. Inhibition by DAF 
prevents continuation of the complement cascade and subsequent target cell lysis 
[21,  59, 68, 69, 70, 84] . HRF (MW 65-70 kDa) and CD59 (MW 18-20 kDa) are 
inhibitory glycoproteins which interfere with the assembly of the terminal 
complement proteins comprising the MAC (C5b-C9). Both HRF and CD59 exert 
their inhibitory action by interferring with the binding of components C8 and C9 
to the forming MAC [38, 87, 109, 1 1 1, 130] . Specifically, CD59 has been shown 
to bind to the a-chain of C8 and the "b" domain of C9 thereby preventing the 
interaction of the two proteins with each other. The ability of CD59 to bind to 
either the C5b-8 or C5b-9 complex serves to limit poly-C9 polymerization within 
cell membranes and restrict pore formation and subsequent cell lysis [86] . CD59 
has been given numerous names by different investigators, including membrane 
inhibitor of reactive lysis, H19, 1FSag, Pl8'-20, and protectin [ 18, 37, 38, 7 1, 88, 89, 
102, 1 13, 1 14, 127] . 
Complement regulatory molecules have been found on many different cell 
types but their individual distribution varies with their particular function. In 
addition to the presence of complement regulatory proteins, pathogenic bacteria, 
protozoa, tumor cells, erythrocytes and platelets utilize additional mechanisms to 
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protect their membranes following complement attack in order to prevent 
complement-mediated lysis [51, 75, 76, 77]. Mechanisms of complement evasion 
can occur at numerous sites along the complement cascade [46]. Evasion may 
occur because the complement pathway is not properly activated or because the 
pathway is blocked prior to formation of the MAC [54]. Neutrophils, erythrocytes, 
platelets and some protozoa evade complement lysis by the physical removal of 
membrane attack complexes from their cell surface in the form of membrane 
vesicles, a mechanism termed vesiculation [26, 75, 76, 77]. In addition, cells may 
rapidly degrade or inactivate the complement components once deposited on the 
membrane surface [50, 75, 77]. 
Complement and parasites 
The interaction of complement with parasitic organisms such as protozoa 
and helminths has been described [108]. Both the classical and alternative 
complement pathways are activated in vivo and in vitro by parasitic organisms. 
However, a number of parasites escape complement-mediated lysis by either 
synthesizing complement regulatory proteins, acquiring host complement 
regulatory proteins or by inactivating specific components of the complement 
pathway. E. histolytica is an intestinal amoeba which activates the ACP, however 
only virulent strains resist complement-mediated damage [41, 72, 73, 97, 98]. 
Passage of amoebae through mice or hamsters maintains pathogenicity and 
complement-resistance. Growth of pathogenic amoebae in the presence of active 
complement also maintains complement resistance in vitro. A correlation 
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between complement resistance and pathogenicity of E. histolytica has been 
demonstrated [72]. Complement has been shown to be involved in host defense 
to infection by E. histolytica since complement depletion using cobra venom factor 
enhances liver abscess formation in hamsters [11]. Reed et aL [97] demonstrated 
that pathogenic strains of E. histolytica deplete or bind complement proteins more 
rapidly as compared to nonpathogenic strains of amoebae. However, the 
mechanism by which pathogenic E. histolytica resists complement lysis is not 
clearly defined. Antisera to the galactose-specific adherence lectin, a major surface 
glycoprotein of E. histolytica was shown to increase the susceptibility of 
complement-resistant E. histolytica suggesting that this surface protein may be 
involved in regulating complement [8]. Others have suggested that restriction of 
additional C9 binding may be involved in conferring resistance to complement in 
vitro [8, 99]. A similar mechanism has been attributed to HRF and CD59. 
Sequence similarities between the adherence lectin and CD59 corroborates the 
hypothesis that these two proteins possess similar complement regulatory abilities 
[8]. In addition to the presence of complement-inhibitory proteins, it has been 
hypothesized that complement-resistant strains of E. histolytica are capable of 
endocytosing the MAC in order to prevent complement-mediated lysis [26 ]. 
Bloodstream forms of the parasite, Trypanosoma cruzi, are resistant to lysis 
by complement [9, 42, 47,50, 54, 55]. Enzymatic treatment studies suggests that 
trypanosomal surface proteins may be involved in the mechanism of complement 
regulation of T. cruzi. Trypomastigotes of T. cruzi (strains M88 and Y) synthesize 
an 87-93 kDa glycoprotein which possesses 40-50% sequence homology and have 
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functional homology to the complement-regulatory molecule, DAF [ 16, 30, 47, 50, 
55, 101] .  Amastigotes of T. cruzi are protected from complement-mediated lysis 
due to an inability of the terminal complement proteins, C5b-9 to insert in the 
plasma membrane of the parasite, a mechanism analogous to HRF or CD59 of 
mammalian cells. 
The promastigote stage of Leishmania spp. activates complement resulting 
in the deposition of C3b on the surface of the parasite. The major surface 
glycoprotein of L. major is a promastigote surface protease (GP63) which cleaves 
complement component C3b into an inactive form, C3bi. This inactive form 
enables L. major to evade complement lysis by inhibiting further complement 
activation [6, 15]. The C3bi fragment also acts as a ligand for the binding to 
complement receptors on macrophages, allowing L. major promastigotes to enter 
into host cell macrophages and further evade the host's immune system [6, 78] . In 
addition to the presence of GP63, L. major possesses a second major cell surface 
protein termed lipophosphoglycan (LPG) which has been proposed to interfere 
with the stable insertion of the MAC (C5b-9) within its cell membrane [95]. Both 
the promastigote surface protease and LPG are attached to the surface of L. 
m ajor by a GPI-anchor [6, 121]. 
Complement activation and deposition on larval schistosomes has been 
reported [ 122] . Cercariae and early skin-stage schistosomula of Schistosom a 
m ansoni possess a high molecular weight glycocalyx consisting of carbohydrates 
and proteins which is highly antigenic and a strong activator of the ACP [23, 107, 
108, 122]. Schistosomula become progressively resistant to ACP-mediated damage 
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by the rapid shedding of the surface glycocalyx which serves as a umque 
mechanism for diverting the immune system [23, 105, 106] . In addition, 
schistosomula incubated in serum-free media shed substances which normally 
consume C3 from serum [64] . This C3 consumption converts the schistosomula 
into a non-activator of the ACP, and renders the schistosomula complement­
resistant [64, 96] . Recently, proteins have been identified on the surface of S. 
m ansoni which regulate complement-mediated lysis. A protein of approximate 
molecular mass 70 kDa is proposed to possess C3b-binding activity, however the 
mechanism is not clearly defined. A second inhibitor prevents MAC formation, 
suggesting that the protein is CD59-like [as cited 24] .  In addition, S. m ansoni also, 
have the capacity to acquire regulatory proteins from host tissues such as DAF, 
which then serve to protect the parasite from complement damage [9 1 ] .  
Thus, pathogenic protozoa and helminths have evolved diverse mechanisms 
for escaping complement-mediated lysis and evading the immune system. The 
Naeglerial components which activate complement and modulate the lytic process 
to allow highly-pathogenic Naegleria Jowleri to escape the amoebicidal activity of 
serum are unknown. These studies will allow for the identification of specific 
mechanisms which allow highly-pathogenic N. Jowleri amoebae to escape 
complement-mediated lysis as well as extend our knowledge of the survival 
strategies utilized by pathogenic organisms such as N. Jowleri, to escape the host's 
immune system. The information will provide an understanding of the role of the 
complement system in parasitic infections, and increase our knowledge of the 
mechanisms employed by many pathogens and tumor cells to evade host immunity. 
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More importantly, studies to evaluate the biochemical basis for the transformation 
of free-living organisms such as N. fowlen into highly-virulent human pathogens 
should provide useful insight for establishing successful treatments for this and 
other fatal diseases. 
Study objectives 
The first objective was to investigate the ability of growth medium to 
modulate biochemical and physiological functions of N. fowlen amoebae. 
Specifically, my objective was to evaluate the effect of growth medium on the 
susceptibility of complement-resistant N. fowlen to complement lysis and on 
virulence of the amoebae for mice. Growth medium has been demonstrated to 
effect a number of physiological and biochemical factors in N. fowlen amoebae 
such as temperature tolerance, enflagellation, rate of locomotion, food-cup 
formation and susceptibility to drug treatment [ 14, 63] .  
The second objective of this study was to examine and compare surface 
proteins of highly-pathogenic, weakly-pathogenic and nonpathogenic Naeglena in 
order to identify specific proteins which may play a role in resistance of 
pathogenic amoebae to complement-mediated lysis. Previous studies have 
demonstrated that treatment of highly-pathogenic, complement-resistant N. fowlen . 
with papain or trypsin, to remove surface proteins increased the susceptibility of 
highly-pathogenic amoebae to complement lysis. Enzymatic treatment of weakly­
pathogenic or nonpathogenic amoebae had no effect on complement lysis [ 126] . 
The third objective of this study was to determine whether pathogenic N. 
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Jowleri use additional biochemical or cellular mechanisms, such as membrane 
vesiculation, for resisting complement-mediated damage. It is well established that 
a number of pathogenic bacteria and nucleated cells resist complement damage 
by the physical removal of complement proteins, specifically the MAC from their 
cell surface via exocytic processes, a process termed membrane vesiculation [77, 
76] . 
Materials and Methods 
Amoebae 
N. Jowleri LEE (ATCC 30894) was isolated in 1968 at the Medical College 
of Virginia Hospital in Richmond, Virginia, from the brain of a patient with 
primary amoebic meningoencephalitis [8 1]. This strain has been cultured 
axenically in the laboratory since its isolation and is weakly-pathogenic in mice. 
N. Jowleri LEEmpCl, a highly-pathogenic strain in experimental animals, 
was derived from the LEE strain by passaging the amoebae through B6C3F 1 mice 
at monthly intervals. Mice were infected intranasally with amoebae. Mter 4 days, 
amoebae obtained from samples of brain from infected mice were cultured 
axenically in Nelson medium or Cline medium at 37°C for a period of not more 
than 1 month. After 1 month of in vitro axenic culture, the amoebae were 
passaged again through mice. After 75 consecutive mouse-passages at monthly 
intervals, the amoebae were cloned by serial dilution in micro titer well plates to 
obtain one amoeba per well. Wells containing one amoeba were grown to 
confluency and serial dilutions of the cultures were continued for 20 growth cycles.  
A highly-pathogenic strain of N. Jowleri, LEEmpCl (LEE mouse-passage Clone 1) 
which consisted of a homogeneous population was used for these studies. The 
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strain used in these studies has been passaged through mice a minimum of 100 
times. 
N. gmberi (EGB), a nonpathogenic, complement-sensitive soil isolate, was 
grown in Cline medium at 30°C [ 1 10, 125] .  Cultures of amoebae were grown 
axenically in 75 cm2 plastic tissue culture flasks (Nunc Inc., Naperville, IL) in 
either Nelson medium or in Cline medium which consisted of equal parts of 
Nelson medium and Balamuth medium [3, 4, 14, 61 ] .  
Amoeba growth medium 
Nelson medium consisted of 0. 1 % (w Iv) liver digest (Panmede; Paines and 
Byrne Limited, Greenford, England), 0. 1 % D-( + )-glucose (Sigma Chemical Co., 
St. Louis, MO) and 2.0% calf serum (BioWhittaker, Walkersville, MD) in Page 
amoeba saline [6 1] comprised of 2 mM NaCI, 0.016 mM MgS04 7H20, 1 mM 
NazHP04' 0.027 mM CaCl2 2H20, 1 mM KH2P04. 
Cline medium [ 14] consisted of 0.55% (w/v) liver digest, 0.3% (w/v) 
glucose, 0.5% (w Iv) Bacto-Peptone (Difco Laboratories, Detroit, MI), 0.25% yeast 
extract (Difco), 1.0% calf serum and 0. 1% (w/v) bovine hemin (Sigma) in Page 
amoeba saline. 
Complement reagents 
Normal guinea pig complement (NGPC) or normal human serum (NHS) 
which served as the complement source were purchased from Sigma or Gibco 
Laboratories (Grand Island, NY), dispensed into vials and stored at _70°C. 
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Purified complement component, C9, and C9-deficient NHS were purchased from 
Sigma or Quidel (San Diego, CA). Polyclonal rabbit antiserum to the human 
complement proteins comprising the membrane attack complex (anti-MAC) was 
purchased from CalBiochem (LaJolla, CA). Monospecific polyclonal rabbit 
antiserum to human erythrocyte CD59 was a provided by Dr. Peter Sims at the 
Wisconsin Blood Center (Milwaukee, WI). 
Amoeba growth rate 
Erlenmeyer flasks containing 50 ml of either Nelson medium or Cline 
medium were inoculated under sterile conditions with 1 x 1<r amoebae per ml and 
allowed to grow at 37°C with gentle agitation in a shaker incubator for 5 d. At 
approximately 24 h intervals, aliquots of the mixture were removed, and the 
number of amoebae were quantitated using a hemacytometer. Counts represent 
the mean number of amoebae determined from 5 separate flasks with a minimum 
of 5 counts per flask. 
Amoebicidal assay 
Log-phase cultures of Naegleria amoebae were labeled for 24 h with 50J..l.Ci 
of [3H]uridine (New England Nuclear/Dupont, Boston MA) at 37°C for both 
strains of N. fowleri or at 30°C for N. gmberi. Amoebae were harvested by 
centrifugation, washed three times in Hank's balanced salt solution (HBSS) to 
remove unincorporated [3H]uridine label and suspended in either gelatin veronal 
buffer (GVB+ +) or HBSS. Amoebae were counted using a hemacytometer and 
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adjusted to a cell density of 1 x 106 amoebae per ml. NGPC or NHS was diluted 
in either G VB + + or HBSS, placed into 96-well microtiter plates (Nunc) and mixed 
with (1 x lOS) [3H]uridine-Iabeled amoebae for 1 h at 37°C. Following incubation, 
the supernatant fluid and pellet were harvested separately and the counts per 
minute (CPM) in each determined. The percent specific release of radiolabel 
from the amoebae was determined using the following formula: 
CPM experimental - CPM spontaneous 
% Specific Release = ---------------- x 100 
CPM maximum release - CPM spontaneous 
The percent specific release of radiolabel was used as an index of cell lysis [ 125] .  
All data were analyzed statistically using the two-tailed Student's t test. 
Determination of alternative pathway-complement hemolytic (AP-CHso) units 
The percent of complement hemolytic units depleted from NHS following 
incubation with N. Jowlen LEEmpC1 was measured by ACP activation [94] . NHS 
or buffer was diluted with 10 mM Mg-EGTA and incubated with N. Jowleri 
amoebae (1  x lOS) or buffer. Following incubation, cell-free serum or buffer was 
added to a series of test tubes containing 1 x 107 rabbit erythrocytes suspended in 
Mg-EGTA, and incubated for 60 min at 37°C with gentle agitation. Following 
incubation, 2 ml of isotonic saline were added to all the tubes to stop the reaction. 
Tubes were centrifuged to pellet remaining intact erythrocytes and the optical 
density (OD) of the supernatant fluid was determined at 4 14 nm. Parallel tubes 
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containing Mg-EGTA buffer and rabbit erythrocytes were incubated for 60 min 
at 37°C and 2 ml of distilled water were added to the mixture to produce 100% 
lysis to serve as a positive control. The proportion of cells which were lysed (y) 
in each tube was calculated using the following formula: 
OD414 sample tube - OD414 cell blank 
y = -----------------------------------------------
OD414 100% lysis tube - OD414 cell blank 
The value of K, a constant representing the 50% unit of complement (x intercept) 
was obtained by plotting log (x) against log [Y/(l-y)], where x is the volume (JLl) 
of serum added to each tube. The number of AP-CHso units/ml equals the initial 
dilution of the serum used multiplied by a factor of 1000. Values are expressed 
as the percentage of complement hemolytic units depleted as compared to the 
initial complement hemolytic activity of the serum prior to incubation with N. 
Jowlen amoebae. 
Effect of supplemental hemin on susceptibility of N. fowleri to complement lysis 
Log-phase cultures of N. Jowlen LEEmpC1 amoebae were grown in Nelson 
or Cline medium supplemented with bovine hemin (0. 1%) for a minimum of 20 . 
days. Amoebae were labeled for 24 h with 50JLCi of [3H]uridine at 37°C and 
susceptibility to complement lysis was determined using the amoebicidal assay 
described above. 
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Media shift of N. fowleri in the absence or presence of cycloheximide 
Log-phase cultures of N. Jowleri LEEmpCI grown in either Nelson or Cline 
medium for a minimum of 20 days were labeled for 24 hr at 37°C with 50 J,£Ci of 
[3H]uridine. Nelson medium was removed from the flasks containing [3H]uridine­
labeled amoebae and replaced with Cline medium. The amoebae were allowed 
to incubate for an additional 2 to 4 h. Amoebae maintained in Nelson medium 
or Cline medium served as controls. Parallel cultures of 3[H]uridine-Iabeled 
amoebae grown in Nelson medium were pretreated with 5J,£g/ml of cycloheximide 
for 4 h followed by a 2 h shift to growth in Cline medium containing 
cycloheximide. Following incubation, amoebae were harvested and incubated in 
NGPC for I h at 37°C. The percent specific release of radio label was determined 
by the amoebicidal assay. 
Autoradiographic analysis of metabolically-labeled N. fowleri subjected to medium 
shift To identify polypeptides synthesized during media shifts, N. Jowleri 
LEEmpCI maintained in axenic culture for a minimum of 20 days, were grown to 
confluency in 25-cm2 plastic tissue culture flasks in either Nelson or Cline medium 
at 37°C. Amoebae maintained in Nelson medium were shifted to growth in Cline 
medium containing Tran35[S]methionine:cysteine radiolabel (ICN Biomedicals, 
Inc., Irvine, CA) for 2 h at 37°C. Following radiolabeling, the amoebae were 
harvested by centrifugation, washed in HBSS and subjected to lysis with a lysis 
buffer cocktail consisting of 2 mM Tris, 100 mM NaCI, 2% (v/v) Triton X- IOO, 
0.5 % (w/v) sodium deoxycholate and 4 mM NaN3 containing the protease 
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inhibitors : 0.2 U/ml aprotinin, 0. 1 mM phenylmethylsulfphonyl fluoride (PMSF) 
and 5 mM iodoacetamide (Sigma). The protein concentration of the lysates was 
determined using a modified Bradford's protein microassay [7] . Radiolabeled 
proteins (50 I-'g) were separated by sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) [56], the gels dried on Whatman paper (BioRad) 
under vacuum and heat and exposed at _70°C to RP X-Omat XRP-5 diagnostic 
film (Eastman Kodak Co., Rochester, NY) for 14 d. 
Image analysis 
Autoradiographic films were analyzed in a Shimadzu CS9000U Dual­
Wavelength Flying-spot Scanner (Shimadzu Corp., Kyoto, Japan) interfaced to a 
WIN 286 computer (Win Laboratories Ltd., Fairfax, VA) employing Quantascan 
2D Analysis binary format and ASCII Conversion software (Shimadzu Corp.) .  
ASCII-converted files were analyzed further on a V AXcluster Computer System 
(Digital Equipment Corp., Richmond, VA) using Statistical Analysis 
System/Graph (SAS/GRAPH) software (SAS Institute, Inc., Cary NC). 
SAS/GRAPH-analyzed data were subjected to final analysis using a WIN 386 
Computer (Win Laboratories) utilizing QGEL Analysis Software (HBI, 
Saddlebrook, NJ) .  Band intensities were integrated and quantitated resulting in 
a relative density volume value used for comparative analyses. 
Virulence of N. fowleri for mice 
Virulence studies were conducted using 8-week old female B6C3Fl mice. 
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Mice were inoculated intranasally with N. Jowleri LEEmpC1 amoebae ( 1  x Hf) 
grown for approximately 10 or 30 d in either Nelson or Cline medium. The 
number of deaths in each group was recorded daily for 30 d. On day 30, surviving 
mice were sacrificed and autopsied to determine whether brain tissue contained 
amoebae. 
Enzymatic treatment of live NaeKleria trophozoites 
Log-phase cultures of pathogenic and nonpathogenic Naegleria spp. were 
radiolabeled with [3H]uridine for 24 h at 37°C or 30°C respectively. Trophozoites 
were harvested by centrifugation, washed free of excess radiolabel and adjusted 
to a cell density of 1 x 106 amoebae per ml. Aliquots (1 ml) of diluted amoebae 
were placed in 1 .5 ml polypropylene microfuge tubes (American Scientific, 
Columbia, MD) and treated with 500mU phosphatidylinositol-specific 
phospholipase C (PIPLC) purified from Bacillus thuringiensis (ICN Biochemicals, 
Cleveland, OH) for 1 h at 37°C with gentle agitation. Following enzymatic 
treatment, PIPLC-treated amoebae were removed and washed free of PIPLC. 
Radiolabeled PIPLC-treated or untreated amoebae were incubated with diluted 
NGPC in 96-well microtiter plates and the percent specific release of radiolabel 
was determined using the amoebicidal assay. 
eH]uridine-labeled Naegleria spp. (1 x lOS) were incubated with 40mU of 
Endo-B-N-acetylglucosaminidase H (endo H) from Streptomyces lividans 
(Boehringer-Mannheim Biochemicals, Indianapolis, IN) diluted in a mixture of 
phosphate buffered saline (PBS) and HBSS pH 7.0 for 4 h at 37°C. Following 
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incubation, the enzyme was removed and amoebae were washed twice with a 
mixture of PBS and HBSS, suspended in GVB + + and incubated with diluted 
NGPC for 1 h at 37°C. The percent specific release of radiolabel was determined 
using the amoebicidal assay. 
Tunicamycin treatment of N aea=leria amoebae 
Log-phase cultures of pathogenic and nonpathogenic Naegleria amoebae 
were grown in [3H]uridine-containing Cline medium in the absence or presence 
of 2.0 or 3.0 J,£g/ml of tunicamycin (Sigma Chemical Co., St. Louis , MO) for 18  
h at 37°C or  30°C respectively. Following incubation, amoebae were harvested 
by centrifugation and washed in HBSS to remove excess tunicamycin. Amoebae 
were counted and 1 x lOS amoebae were incubated in diluted NGPC for 1 h at 
37° C. Parallel cultures of amoebae were grown in Cline medium in the absence 
or presence of tunicamycin for 18 h, followed by removal of the drug and 
incubation in tunicamycin-free growth medium for 24 h. Amoebae were harvested 
as described above and incubated in NGPC for 1 h at 37°C. The percent specific 
release of radiolabel from the amoebae was determined using the amoebicidal 
assay. 
Determination of protein synthesis inhibition in Naea=leria amoebae 
Naegleria amoebae were radiolabeled with 30J,£Ci/ml [35S]methionine (New 
England Nuclear/DuPont) in Cline medium. Labeling of cells with [35S] 
methionine in the presence of tunicamycin was performed either immediately or 
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after appropriate preincubation periods with the drug. After radiolabeling, the 
amoebae were washed twice with cold HBSS and subjected to lysis using the lysis 
buffer cocktail. Incorporation of [35S]methionine into newly synthesized proteins 
was determined by precipitation using 5% (v Iv) trichloroacetic acid (TCA) at 00 C. 
The precipitates were collected onto 0.45J.'m nitrocellulose filters (Millipore Filter 
Corp, Bedford, MA), washed with 10 ml of 5% TCA containing 2mg/ml 
methionine, dried and counted in 4 ml of Beckman Ready Protein scintillation 
cocktail (Beckman Instruments Inc., Fullerton, CA). The protein concentration 
of the pellets was determined and the specific activity (cpm/ J.'g protein) was 
determined using the formula: 
cpm/ J.'l TCA precipitated protein 
Specific Activity = 
J.'g protein/I.d of sample 
Precipitates were analysed by SDS-PAGE and the polypeptide bands were 
detected by staining with Coomassie Brilliant Blue R-250 (BioRad, Rockville 
Centre, NY) at a final concentration of 0. 125%. Following staining, the gels were 
dried on Whatman paper (BioRad) under vacuum and heat and then exposed at 
_70°C to diagnostic film (Eastman Kodak Co.) for 14 days. 
Surface Iodination of Nae&leria amoebae 
Sterile glass vials were coated with 100J.'g of iodogen ( 1,3,4,6-tetrachloro-
3a,6a-diphenylglycouril) (Pierce Chemical Co., Rockford, IL), by dissolving 
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iodogen in chloroform and drying under a stream of N2• Vials were stored 
dessicated at 4°C. Amoebae were washed in HBSS to remove residual growth 
medium. Amoebae were harvested by centrifugation and incubated at room 
temperature for 15 min in iodogen-coated vials in the presence or absence of 500 
#loCi of Nal251 with intermittent swirling. Following incubation, amoebae were 
washed in cold HBSS containing 5 mM potassium iodide (KI) and subjected to 
lysis using the lysis buffer cocktail as described previously. Incorporation of 1251 
into protein was determined by precipitation using a mixture of 5% TCA 
containing 0.3 mg/ml KI and 150 mM NaCI containing 0.5% fetal calf serum at 
O°C. Precipitates were pelleted by centrifugation and the CPM present in the 
supernatant fluid and pellet were quantitated using a gamma counter. The 
concentration of protein in the pellets was determined as described above. 
Samples of precipitated protein were analyzed by SDS-PAGE and Coomassie 
Brilliant Blue staining. The gels were dried on Whatman paper under vacuum and 
heat and exposed to film at room temperature for 28 h. 
Trypan blue exclusion of iodinated Nae21eria amoebae 
Viability of amoebae following surface iodination was assessed by mixing 
equal volumes of amoebae with a 4% trypan blue (Sigma) solution following . 
iodination in iodogen-coated vials. The amoebae were examined for exclusion of 
dye using a hemacytometer and phase contrast microscopy. The ratio of live 
versus dead amoebae was determined and the percent viability calculated. 
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Biotinylated lectin analysis of NaeKleria amoebae 
Lysates of amoebae subjected to surface iodination were used also, for 
glycoprotein determination. Radiolabeled amoebic lysates (25J..Lg) were separated 
by SDS-PAGE and the proteins were transferred to nitrocellulose. Glycoproteins 
were detected using VECfASTAIN ABC reagents (Vector Laboratories 
Burlingame, CA). Briefly, nitrocellulose membranes were incubated in Tris­
buffered saline pH 7.5 containing 0. 1% Tween-20 (Sigma) (TTBS) for 30 min. 
Nitrocellulose membranes were incubated for 45 min with 20J..Lg/ml of either 
biotinylated Concanavalin A or biotinylated Ulex europaeus agglutinin I suspended 
in TTBS with gentle agitation. Following incubation, membranes were washed 3 
times with TTBS and incubated for 30 min in horseradish peroxidase-conjugated 
Avidin-D ( lOJ..Lg/ml). Membranes were washed as before and developed using a 
substrate solution containing diaminobenzidine-hydrochloric acid, H202, and NiCI 
(Sigma). After development, the nitrocellulose blots were subjected to 
autoradiography at _70°C for 4 days. 
Anti-CDS9 immnnostaining of NaeKleria amoebae 
Lysates from pathogenic and nonpathogenic Naeg/eria were generated using 
the lysis buffer cocktail as described. Erythrocyte ghosts were prepared by 
washing fresh erythrocytes extensively in 5 mM phosphate buffer (KH2P04). 
Hemoglobin-free erythrocyte ghosts were pelleted by centrifugation at 3000 xg for 
10 min. Pellets were subjected to a freeze-thaw cycle and the protein 
concentration determined. Lysates from amoebae and erythrocyte membranes 
29 
were subjected to 12% SDS-PAGE under non-reducing conditions and western 
immunoblot analysis. Rainbow molecular weight markers (Amersham, Arlington 
Heights, IL) were used to determine the relative molecular mass of the proteins . 
Proteins were transferred to 0.45J,.£m nitrocellulose membranes (BioRad) in a 
BioRad Transblot apparatus overnight at 90 rnA (30 constant volts). 
Nitrocellulose membranes were blocked with phosphate buffered saline (PBS) 
containing 5% (w Iv) nonfat dry milk, 5 mM (w Iv) ethylenediamine tetraacetic 
acid (EDTA), 0.01% (v/v) antifoam A (Sigma) and 0.0001% (w/v) thimerosal 
[45] .  Membranes were incubated overnight in monospecific polyclonal antiserum 
to human erythrocyte CD59 diluted in the blocking buffer. Membranes were 
washed and incubated with peroxidase-conjugated secondary antiserum. Antibody 
reactivity was visualized using 3 mM (w Iv) chloronapthol (Sigma), 0.015% (v Iv) 
H202, 16.7 % (v Iv) methanol in tris-buffered saline (TBS) pH 7.4. 
Immunofluorescence microscopy of Naea:leria amoebae 
Trophozoites of pathogenic and nonpathogenic Naegleria amoebae were 
placed on 12 mm round cover glasses and allowed to attach at 37°C. NHS 
diluted in HBSS was added to the cover glasses and allowed to incubate for 15 
min to 1 h at 37°C. Following incubation, the cover glasses were removed and 
extensively washed to remove unbound serum proteins. Cover glasses containing 
serum-treated amoebae were fixed with warm (37°C) 0.25% (w/v) 
paraformaldehyde for 2 h at 37°C. Following fixation, cover glasses were 
removed from the paraformaldehyde and allowed to air dry overnight. Cover 
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glasses were rehydrated with 1 M PBS pH 7.2 and blocked with 0. 1 %  bovine 
serum albumin (BSA). Cover glasses were stained with either affinity-purified 
rabbit polyclonal antiserum to human CD59 or rabbit polyclonal antiserum specific 
for human complement proteins comprising the membrane attack complex (C5b­
C9) (CaIBiochem). Fluorescein isothiocyanate-Iabeled goat anti-rabbit IgG 
antiserum (Sigma) was used to visualize antibody reactivity. Cover glasses were 
mounted on glass slides and viewed by fluorescence microscopy with an Olympus 
BH-2 microscope. 
Immunoprecipitation of amoebic Iysates using CD59 antiserum 
Pathogenic and nonpathogenic Naegleria were radiolabeled with 100J,£Ci/ml 
of Tran[35S]label (methionine:cysteine) in Cline medium. Amoebae were washed 
in HBSS and cell pellets were treated with 1 ml of lysis buffer [50 mM tris-HCI 
pH 7.4, 0.5% (v/v) nonidet P40, 0. 15 M NaCI, 0.02% (w/v) NaN3, 5 mM EDTA, 
0. 1 mM PMSF] for 2 h at 4" C with gentle agitation. Incorporation of [35S] 
methionine:cysteine into newly synthesized proteins was determined by TCA 
precipitation using Skatron filters (Skatron, Inc., Sterling, VA). Aliquots of 
radiolabeled cell lysates containing a constant number of TCA precipitable counts 
(5 x 106) were incubated with 25 J,£g of CD59 antiserum at 4"C for 16 h. 
Following incubation, a two-fold excess of a 50% (w Iv) protein A Sepharose bead 
suspension was added to the mixture and the mixture was incubated for an 
additional 2 h at 4" C. All incubations were performed with gentle agitation. The 
sepharose beads were washed twice each with lysis buffer, with PBS containing 
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0.05 % sodium azide and with 0. 1 % SDS. The washed beads were combined with 
50j.LI of 2X sample solubilization buffer [0. 125 M tris-CI, pH 6.8, 4% SDS, 20% 
glycerol, 0.05% (w/v) bromophenol blue] and heated to lOO°C for 5 min. The 
sepharose beads were pelleted by centrifugation and the supernatant fluid 
separated on a 15% SDS-PAGE. Gels were fixed in 40% methanol/l0% acetic 
acid, treated with EN3HANCE autoradiography enhancer (NEN Research 
Products, Boston, MA), dried and exposed to film for 14 d at -70°C. 
Generation of polyclonal antiserum to Nael:leria-specitic proteins in mice 
PolycIonal antibodies to specific proteins from highly-pathogenic N. lowlen 
were prepared in B6C3Fl mice. Initially, mice were bled from the lateral tail vein 
to obtain pre-immune serum. Lysates from highly-pathogenic N. lowlen were 
separated by SDS-PAGE and stained with Coomassie blue to identify specific 
bands of interest. Specific protein bands were excised from the acrylamide gel 
and equilibrated in PBS for 2 h with gentle agitation. Gel slices containing 
protein were homogenized by passage through an 18 gauge needle, aliquoted into 
equal volumes of PBS and stored at _70°C. Mice were inoculated 
intraperitoneally with protein-containing homogenized gel slices emulsified in an 
equal volume of Freund's complete (50%) and incomplete (50%) adjuvant. After 
a three week rest period, mice were given a booster injection. One week later, 
blood was collected from the tail vein. The blood was allowed to clot at 4 °C. 
The serum was removed and stored at _70°C. 
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Effect of antibody on susceptibility of Nae�leria to complement lysis 
NaegZeria amoebae grown in Cline medium were radiolabeled with 50J,.LCi 
of eH]uridine for 24 h. Amoebae were harvested by centrifugation and washed 
in HBSS. Amoebae (1 x lOS) were incubated in the presence or absence of 
polyclonal antiserum (rabbit antiserum to human CD59 or mouse antiserum to N. 
JowZeri-specific proteins) for 1 h at 4°C. Following incubation, NHS diluted in 
HBSS was added and the mixture was incubated for 1 h at 37°C. Supernatant 
fluid and pellets were harvested and the CPM in each determined as described in 
the amoebicidal assay. The percent specific release of radiolabel was determined 
and used as an index of lysis. Pre-immune antiserum (rabbit or mouse) was used 
to assess whether the antiserum was complement fixing for NaegZeria amoebae. 
Northern analysis of Nae�leria amoebae 
Preparation of E. coli competent cells: E. coli (DH5a) were grown to an 
OD600 of 0.4. Bacteria ( 1 .0 ml) were aliquoted and placed into microfuge tubes. 
Bacteria were pelleted by centrifugation at 10,000 rpm (6000 x g) for 5 min. 
Pellets were suspended in 100J,.LI of TSS solution [0.5 g tryptone, 0.25 g yeast 
extract, 0.5 g NaCI, 5 g polyethyleneglycol (PEG) MW 8000 pH 6.5, 0.5 rnl 
dimethylsulfoxide (DMSO), 0.2 ml MgCI2] and stored at _70°C for 2-3 months. 
Transformation of competent cells: Competent cells were incubated with 
O.4J,.Lg of plasmid DNA [pUC19-CD59 or pBR322-GPD] on ice for 30 min. One 
milliliter of SOC medium (2% bacto-tryptone, 0.5% yeast extract, 10 mM NaCI, 
2.5 mM KCI, 10 mM MgCI2, 10 mM MgS04, 20 mM glucose) was added and the 
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mixture incubated at 37°C with shaking 200 rpm for 1-2 h. The cells were plated 
onto antibiotic selective LB plates [ampicillin for pUCI9-CD59; tetracycline for 
pBR322-GPD] containing 1% (w Iv) tryptone, 0.5% (w Iv) yeast extract, 0.5% 
(w Iv) NaCI, 1% (w Iv) agar and l00J,£g/rnl ampicillin to select for transforrnants. 
Plates were inverted and incubated overnight at 37°C. LB broth containing 1 % 
(w Iv) tryptone, 0.5% (w Iv) yeast extract, 0.5% (w Iv) NaCI and appropriate 
antibiotics was inoculated with a single transforrnant colony and incubated for 5-7 
h at 37°C, 200 rpm to obtain a saturated culture. Saturated cultures (1 ml) were 
inoculated into 100 rnl of antibiotic selective LB broth and incubated overnight at 
37° C, 200 rpm. Cells were harvested by centrifugation at 6000 x g for 15 min at 
4 ° C. Pellets were lysed and plasmid DNA isolated using the Quiagen plasmid 
DNA isolation kit as described by the manufacturer (Quiagen, Chatsworth, CA). 
RNA isolation: Pathogenic and nonpathogenic Naegleria amoebae were 
grown to confluency in 150 cm2 plastic tissue culture flasks (Nunc) in Cline 
medium. Amoebae were gently rinsed with sterile PBS pH 7.4 to remove traces 
of growth medium. Amoebae were lysed with 7.2 rnl of GT buffer consisting of 
4 M guanidine isothiocyanate, 10 mM tris pH 7.4, 7% (v Iv) B-mercaptoethanol in 
diethylpyrocarbonate (DEPC)-treated water followed by the addition of SOOJ,£1 of 
20% sarcosyl solution. Samples were passed through a 23 gauge needle and 
placed into a 16 x 76 mm quick seal centrifuge tube (Beckman). Samples were 
underlayed with CsCI (5.7 M CsCI, 10 mM (w/v) EDTA pH 7.4 in DEPC-treated 
water) and the tubes sealed. Tubes were centrifuged in a Ti50 fixed angle rotor 
at 40K for 16-20 h at IS°c. Tubes were immediately removed and the 
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supernatant fluid discarded. Pellets were rinsed with room temperature 100% 
ethanol and suspended in DEPC-treated sterile water. The mixture was diluted 
with sodium acetate pH S.O to a final concentration 0.3 M. RNA was precipitated 
with two volumes of ice-cold 9S- 1OO% ethanol and incubation at _70°C overnight. 
RNA was pelleted by centrifugation in a microfuge (Costar, Cambridge, MA) at 
4°C for S min. Pellets were air dried and suspended in DEPC-treated water. The 
concentration of RNA was determined by optical density at 260/280. 
RNA electrophoresis : RNA was subjected to 1 % agarose gel 
electrophoresis (1 % agarose, IX MOPS, 3 M sodium acetate, O.S M EDTA pH 
7.4, 0. 18% formaldehyde) at 30V overnight with circulation. RNA (kB) markers 
(Gibco-Bethesda Research Laboratories, Gaithersburg, MD) were separated by 
electrophoresis to allow for RNA size determination. The quality and equivalent 
loading of RNA was evaluated by ethidium bromide staining. Gels were 
equilibrated in 20 X SSC (3M NaCI, O.3M N�C6H504 or sodium citrate) for 20 
min and the purified RNA transferred to QiaBRANE O.4SJ,.£m nitrocellulose 
membranes (Qiagen) by capillary transfer. RNA was crosslinked to the 
nitrocellulose membranes using a UV Stratalinker (Stratagene, LaJolla, CA). 
Probes: The pUC19 plasmid vector containing the full length human CDS9 
cDNA was provided by Dr. Alfred Bothwell (Yale Medical School, New Haven, 
CT). The cDNA for CDS9 was isolated from a i..gtlO cDNA library constructed 
from the human myelogenous leukemia cell line K-S62. The clone was digested 
with EcoR1 [93]. The resulting fragments were separated by agarose gel 
electrophoresis and the SOO bp fragment containing CDS9 cDNA was excised, 
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eluted and purified. The pBR322 plasmid vector containing the glyceraldehyde 
3-phosphate dehydrogenase (GPD) cDNA was digested with PstI [ 1 16] .  The 
fragments were separated by agarose gel electrophoresis and the 1 .3 kB fragment 
containing GPD cDNA was excised, eluted and purified. cDNA probes were 32p_ 
labeled by nick-translation and used as probes for Northern blot analysis. 
Radiolabelin� of DNA by nick-translation: Plasmid DNA (5JLg) containing 
cDNA probe inserts was digested with restriction enzymes to separate the cDNA 
inserts. Inserts were excised from the gel and the cDNA extracted using the 
QIAEX gel extraction kit (Qiagen). Extracted DNA was radiolabeled with 32p_ 
dCfP (NEN) by Nick Translation using methods described by Gibco-BRL. 
Radiolabeled DNA was separated from unincorporated nucleotide using NICK 
columns (Pharmacia LKB Biotechnology, Piscataway, NJ) as described by the 
manufacturer. 
Hybridization conditions: Nitrocellulose membranes containing RNA were 
incubated in prehybridization buffer [50% (v Iv) formamide, 0. 1% (w Iv) BSA, 
0. 1 %  (w/v) Ficoll 400, 0. 1% (w/v) polyvinyl-pyrrolidone 40, 0.005% (v/v) SDS, 
0.05M NaHP04' 5X SSC, 0.025 % (w/v) yeast RNA] for 3-4 h with gentle 
agitation. Membranes were hybridized for 18 h at 22°C in hybridization buffer 
containing prehybridization buffer, containing 5% dextran sulfate and 1 x 106 
cpm/ml of radiolabeled nick-translated probe with gentle agitation. Membranes 
were washed in 2X SSC/0.2% SDS (4X, 5 min each), in 2X SSC/0.2% SDS ( IX, 
30-40 min), and in 0.5X SSC/0.2% SDS ( IX, 20 min). All washes were performed 
at 37°C. Membranes were allowed to dry and exposed to diagnostic film at _70°C 
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for 48 h. The stringency was increased by increasing the temperature during the 
prehybridization step, the hybridization step and the wash steps. Membrane­
bound probes were stripped by incubating at 95 °C for 5 min in O.OlX SSC/0.01 % 
SDS and rehybridized with 32P-Iabeled GPD cDNA to confirm and quantitate 
equivalant loading of RNA in each lane. 
Nomarski optics microscopy of N. fowleri amoebae 
Trophozoites of pathogenic N. fowleri amoebae were placed onto 12 mm 
round cover glasses and allowed to attach at 37°C for 2 h. Cover glasses 
containing amoebae were incubated for 15 to 30 min with diluted NHS. Following 
incubation, cover glasses containing amoebae were fixed overnight in 2.5% 
glutaraldehyde (Sigma) buffered with 0. 1 M sodium cacodylate (pH 7.2) for 2 h 
at 37° C. Cover glasses were mounted on glass slides and viewed with an Olympus 
BH-2 microscope with Nomarski optics. 
Electron microscopy of N. fowleri amoebae 
Scanning electron microscopy (SEM): Trophozoites of Naegleria amoebae 
grown in Nelson medium or Cline medium were placed onto 12 mm round cover 
glasses in growth medium and allowed to attach at 37°C for 1 h. Cover glasses 
containing amoebae were incubated at 37°C in diluted NHS or buffer for 15-60 
min in an atmosphere of 5% CO2. Cover glasses were fixed with warm (37°C) 
2.5% glutaraldehyde-buffered with 0. 1 M sodium cacodylate (pH 7.2) for 2 h at 
37° c. After a 2 h incubation at 37° C, the cover glasses were incubated overnight 
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at 4°C. The samples were washed with 0. 1 M cacodylate buffre and post-fixed for 
1 h with 1% osmium tetroxide in 0. 1 M sodium cacodylate buffer pH 7.2. Cover 
glasses were washed twice with cacodylate buffer and dehydrated in a series of 
ethanol washes (30%, 50%, 70%, 90% and 100%). The cover glasses were 
subjected to critical point drying and coated with gold. Cells were viewed with a 
JEOL scanning electron microscopy operating at 15 kV. 
Transmission electron microscopy (TEM): Trophozoites of Naegleria 
amoebae grown in Nelson medium or Cline medium incubated in NHS or buffer 
were pelleted by centrifugation and fixed with warm 2.5% glutaraldehyde in 0. 1 
M sodium cacodylate buffer (pH 7.2). Cells were fixed overnight at 4 °C and 
processed for TEM as previously described [62] . The amoebae were viewed with 
a Zeiss transmission electron microscope operating at 65 kV. 
Quantitation of complement protein C9 binding to the surface of N. fowleri 
Complement component C9 was radiolabeled with 500J,LCi of Nal25I 
(Amersham, Arlington Heights, IL) using Iodobeads (Pierce) as described by the 
manufacturer. Unbound iodine was removed by Excellulose GF-5 Desalting 
chromatography (Pierce) .  Specific binding of radiolabeled C9 to highly-pathogenic 
N. Jowleri amoebae was determined using a modification of the procedure 
described by Joiner [48, 49] . Briefly, N. Jowleri were harvested by centrifugation 
and washed twice in HBSS. Amoebae were counted using a hemacytometer and 
suspended at a concentration of 1 x 106 amoebae per 100J,L1. Amoebae ( 1  x 106) 
were added to silicon-coated tubes (Costar, Cambridge, MA) and pelle ted by 
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centrifugation at 10,000 rpm (6000 x g) for 10 min. Supernatant fluid was 
removed and specific binding of 125I_C9 was determined by incubating N. Jowleri 
LEEmpCl with C9-deficient NHS reconstituted with 125I_C9 (0.6J,£g) for 30 min. 
Nonspecific binding of 125I-C9 to amoebae was measured by incubating amoebae 
in heat-treated (50°C for 20 min) containing 125I-C9 (0.6J,£g). Following 
incubation, the solution was layered onto an oil cushion and centrifuged at 6000 
x g for 6 min. The supernatant fluid was harvested and the tubes containing the 
cellular pellet and oil cushion were collected and the cell-associated radioactivity 
present in each determined in a gamma counter. Percent specific binding (% SB) 
was calculated using the following formula: 
CPM pellet specific binding - CPM pellet nonspecific binding 
% SB = -------------------- x 100% 
total input CPM 
Quantitative and visual analysis of C9 binding to N. fowleri and release by 
vesiculation 
N. Jowleri amoebae (1 x 106) were harvested and placed into a series of 
silicon-coated microfuge tubes in triplicate. Pellets were generated by 
centrifugation and amoebae suspended in a 1 :8 dilution of C9-deficient NHS 
reconstituted with 125I_C9. Nonspecific binding was determined by incubating 
amoebae in heat-treated (50°C for 20 min) NHS reconstituted with 125I_C9. 
Tubes were incubated for various time intervals from 15 to 120 min at 37°C with 
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gentle agitation to prevent settling of the amoebae. Following incubation, intact 
amoebae and released membrane vesicles were separated using a modification of 
previously described procedures for isolating released membrane vesicles [ 10, 128] . 
First, the mixture was centrifuged at 5000 rpm (1000 x g) for 10 sec to pellet the 
amoebae (pellet 1). The remaining supernatant fluid was gently removed with a 
microcapillary pipet tip and placed in a silicon-coated tube. The tube was 
centrifuged at 10,000 rpm (6000 x g) for 20 min to pellet membrane vesicles 
present in the supernatant (pellet 2). The cpm of radioactivity associated with 
pellet 1, pellet 2 and the final supernatant were determined using a Packard 
Gamma Counter (Packard, Downers Grove, IL). The percent C9 cpm bound to 
pellet 1 and pellet 2 was determined using the following formula: 
CPM specific (pellet 1) - CPM nonspecific (pellet 1) 
% C9 cpm (pellet 1) = --------------------x 100% 
CPM (pellet 1) + CPM (pellet 2) 
Nomarski optics microscopy was performed to verify the contents of each 
pellet. Briefly, pellets and supernatant fluid were generated as described. Pellets 
were subjected to fixation with 50J,.£1 of 2.5% glutaraldehyde in 0. 1 M cacodylate 
buffer. Pellets were suspended in glutaraldehyde and placed onto glass slides. The 
suspension was covered with a round cover glass and sealed to preserve the 
sample. Supernatant fluid was mixed 1 : 1  with 4% glutaraldehyde, mounted on a 
glass slide and sealed. Parallel samples were prepared as described in the absence 
of glutaraldehyde fixation to determine the status of each sample following 
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prolonged incubation periods (2-4 h) of the amoebae and membrane vesicles in 
NHS. 
Cytocbalasin treatment of NaeKleria amoebae 
Log-phase cultures of [3H]-uridine-labeled pathogenic and nonpathogenic 
Naegleria were incubated with either cytochalasin D or cytochalasin B (20J,.£g/ml) 
suspended in growth medium for 2 h at 37°C or 30°C. Following treatment, the 
amoebae were harvested and incubated in NGPC for 1 h at 37°C in the presence 
or absence of drug. The percent specific release of radio label from the amoebae 
was determined using the amoebicidal assay. 
RESULTS 
Growth Medium Studies 
Pathogenic N. Jowleri amoebae were maintained in axenic culture in either 
Nelson medium or Cline medium. Table 1 lists the ingredients in Nelson medium 
and Cline medium. To assess whether medium composition affects the growth 
of pathogenic N. Jowleri, growth curves of both weakly-pathogenic LEE (Figure 
2A) and highly-pathogenic LEEmpC1 (Figure 2B) grown in Nelson or Cline 
medium were generated. Growth curves for N. Jowleri LEE and LEEmpC1 
amoebae grown in the same medium were similar. The growth of both LEE and 
LEEmpC1 in Cline medium exceeded their growth in Nelson medium by 10 fold. 
To determine whether growth conditions modulate complement resistance 
of pathogenic N. Jowleri LEEmpC1, amoebae obtained from infected mouse brain 
were cultured axenically in vitro in two different growth media, Nelson medium 
or Cline medium. In vitro cultured amoebae were radiolabeled with [3H]uridine 
followed by incubation in NGPC to determine their susceptibility to complement 
lysis. Highly-pathogenic N. Jowleri LEEmpC1 amoebae grown axenically for 30 
days in Cline medium remained resistant to lysis by complement (Table 2). In 
contrast, axenic growth of the amoebae in Nelson medium for 30 days resulted in 
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Table 1 :  Composition of growth media for Naegleria amoebae. 
Media (% composition)a 
Ingredients Nelson Cline 
Liver digest 0. 1% 0.55% 
D-( + )-glucose 0. 1% 0.3% 
Bacto-peptone 0.5% 
Yeast extract 0.25% 
Bovine heminb 0. 1% 
Donor calf serumb 2.0% 1 .0% 
Page amoeba saline + + 
a Percentages were calculated on the basis of weight per volume (w Iv). 
b Percentages for donor calf serum and bovine hemin were calculated on the 
basis of volume per volume (v Iv). 
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Figure 2: Growth of two strains of Naeglena Jowlen amoebae in different axenic 
media. The LEE strain was grown in either Cline medium or Nelson medium in 
75 cm2 tissue culture flasks at 37°C prior to growth in a gyrotory shaker. The 
LEEmp strain was passaged through mice and the amoebae were isolated from 
brain tissue by placing infected brain in tissue culture flasks containing either 
Cline medium or Nelson medium for 5 d prior to the growth studies. (A) LEE 
strain grown in Cline medium (solid line) or Nelson medium (hatched line) for 5 
d at 37°C in a gyrotory shaker. (B) LEEmpCl grown in Cline medium (solid line) 
or Nelson medium (hatched line) for 5 d at 37°C in a gyrotory shaker. 
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an increased susceptibility to complement lysis (Table 2) . The susceptibility of 
N. fowleri amoebae to complement-mediated lysis differed significantly depending 
on the medium in which the amoebae were grown and the number of days the 
amoebae were maintained in axenic culture. 
To determine whether modulation of susceptibility to complement was a 
result of differences in the ability of the amoebae to activate the ACP of 
complement, the AP-complement hemolytic (AP-CHso) units remaining in NHS 
following incubation with N. fowleri LEEmpC1 were measured. Pathogenic N. 
fowleri grown axenically in Nelson medium or Cline medium activate the ACP 
equally well as measured by the ability of the amoebae to deplete AP-CHso units 
equally from NHS (Table 2). 
To determine the time point during axenic cultivation that growth medium 
modulates the ability of highly-pathogenic amoebae to resist complement lysis, 
amoebae were inoculated intranasally into B6C3Fl mice. Four days post 
inoculation, the brains from infected mice were harvested and placed into tissue 
culture flasks containing either Nelson medium or Cline medium. The amoebae 
were allowed to migrate from the brain for 6-12 h followed by removal of the 
residual brain tissue and addition of fresh growth medium. The susceptibility of 
the amoebae to complement lysis was determined at different time intervals 
during axenic culture in vitro from 1 to 30 days (Figure 3). Highly-pathogenic 
LEEmpC1 amoebae grown in Nelson medium were resistant to complement­
mediated lysis when grown in axenic culture for approximately 12 days. In vitro 
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Table 2: Susceptibility of highly-pathogenic Naeglena Jowlen to complement lysis 
and the AP-CHso units remaining following growth in different media. 
N. Jowlen # Days Growth media % Lysis8 % of Complement 
amoebae in vitro units depletedb 
LEEmpC1 8 Cline 25.8 ± 1.7 27.9 % 
8 Nelson 24.9 ± 3.0 30.8 % 
LEEmpC1 30 Cline 22.4 ± 1.8 47.8 % 
30 Nelson 50.2 ± 2.5c 35.8 % 
8 [3H]uridine labeled N. Jowlen LEEmpC1 amoebae grown in either Nelson 
medium or Cline medium for 8 days or greater than 30 days were incubated with 
NHS ( 1 :4) for 1 h at 37°C. Each value represents the percent specific release of 
radiolabel ± standard error of the mean from amoebae from a representative 
experiment. 
b NHS was incubated with N. Jowlen LEEmpC1 for 1 h at 37°C. Each value 
represents the percent AP-CHso units depleted from NHS following incubation 
with N. Jowlen amoebae from a representative experiment. The initial hemolytic 
activity of the serum (201 units/ml) was used to calculate the percent AP-CHso 
units depleted. 
c p < 0.01 
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Figure 3: Susceptibility of Naegleria fowleri amoebae to complement-mediated 
lysis after continuous culture in vitro. N. fowleri LEEmpC1 amoebae were grown 
axenically in either Nelson medium or Cline medium for a minimum of 30 days 
following removal from mouse brain. At various time points amoebae were 
radiolabeled with [3H]uridine and incubated with NGPC ( 1 :2) for 1 h at 37°C. 
Each value represents the percent specific release of radiolabel ± standard error 
of the mean from amoebae from a representative experiment. 
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axenic culture of amoebae in Nelson medium for greater than 12 days resulted in 
a statistically significant increase in the susceptibility of the amoebae to 
complement lysis. In contrast, highly-pathogenic LEEmpC1 amoebae grown in 
Cline medium remained resistant to complement lysis following in vitro cultivation 
for time periods greater than 30 days (Figure 3). 
To determine whether the inability of pathogenic N. fowleri to resist 
complement lysis when grown in Nelson medium parallels a loss in virulence, 8-
week old B6C3Fl mice were inoculated intranasally with 1 x 1
<f highly-pathogenic 
N. fowleri LEEmpC1 amoebae grown axenically for either 10 days or 30 days in 
either Nelson medium or Cline medium. The percent mortality of mice 
inoculated with amoebae was determined and used as an index of virulence. A 
100% mortality was observed in mice inoculated intranasally with LEEmpC1 
amoebae which had been cultured axenically in either Nelson or Cline medium 
for 10 days. A 100% mortality was observed in mice inoculated with LEEmpC1 
amoebae grown axenically in Cline medium for 30 days. In contrast, a 40% 
mortality rate was observed in mice inoculated intranasally with mouse-passaged 
LEEmpC1 amoebae grown axenically in Nelson medium for 30 days (Table 3) .  
No amoebae were identified from the brains of mice surviving after inoculation 
with N. fowleri amoebae grown in Nelson medium. 
The ability of growth medium supplemented with bovine hemin to 
modulate complement resistance in vitro was evaluated. N. fowleri amoebae grown 
axenically for a minimum of 20 days in Nelson medium or Cline medium were 
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Table 3 :  Virulence of Naegleria Jowleri amoebae after growth in Nelson medium 
or Cline mediuma• 
N. Jowleri Growth medium Inoculum % Mortality Avg. days to death 
LEEmpCl 
day lOb Nelson 1 x l(f 100 8.6 
Cline l x l<f 100 1 1 .8 
LEEmpCl 
day 30c Nelson 1 x 104 40 18.5 
Cline l x l<f 100 10.3 
a Eight-week old B6C3Fl mice were inoculated intranasally with highly-pathogenic 
N. Jowleri LEEmpCl amoebae grown axenically in either Nelson medium or Cline 
medium for 10 d or 30 d (n = 5). Data are represented in average days to 
death.The number of deaths from a representative experiment was recorded for 
30 d. Similar data were obtained each time the experiment was repeated. 
b N. Jowleri LEEmpCl grown axenically for 10 d in Nelson medium (complement­
resistant) or Cline medium (complement-resistant) . 
e N. Jowleri LEEmpCl grown axenically for 30 d in Nelson medium (complement­
sensitive) or Cline medium (complement-resistant) . 
5 1  
switched to growth medium in the absence or presence of 0. 1% supplemental 
bovine hemin for 4 days (Figure 4). The susceptibility of the amoebae to 
complement lysis was measured using the amoebicidal assay. Growth of N. Jowlen 
amoebae in medium supplemented with 0. 1 % bovine hemin increased the ability 
of the amoebae to resist complement lysis when compared to amoebae grown in 
medium lacking supplemental bovine hemin. However, the ability of N. Jowlen 
amoebae to resist complement lysis when grown in hemin-supplemented Nelson 
medium was less than that of amoebae grown in hemin-supplemented Cline 
medium. The use of higher concentrations of supplemental bovine hemin (0.2% 
or 0.3%) was toxic to the amoebae. 
To determine whether the susceptibility of highly-pathogenic LEEmpC1 
amoebae to  complement when maintained in Nelson medium could be  modulated 
by changes in growth medium, amoebae grown in Nelson medium were shifted to 
growth in Cline medium for 2 h prior to the addition of serum complement. 
Susceptibility of N. Jowlen LEEmpC1 to complement lysis when grown in Nelson 
medium can be decreased by incubating the amoebae in Cline medium for 2 h 
prior to the addition of serum complement (NGPC) (Figure 5) .  In parallel 
experiments, pathogenic LEEmpC1 amoebae grown in Nelson medium for 20 days 
were pretreated with 5 ILg/ml cycloheximide for 4 h, to inhibit protein synthesis. 
Following pretreatment with cycloheximide, the amoebae were shifted to Cline 
medium containing 5 ILg/ml cycloheximide for 2 h and the susceptibility of the 
amoebae to lysis by complement was determined. Inhibition of protein synthesis 
for 6 h in LEEmpC1 amoebae grown in Nelson medium blocked the ability of the 
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Figure 4 :  The effect of  hemin on susceptibility of  Naegleria fowleri to  
complement-mediated lysis. 3[H]uridine-Iabeled N. fowleri LEEmpC1 grown 
axenically in Nelson medium or Cline medium for a minimum of 20 d were 
switched to growth in medium in the absence or presence of supplemental bovine 
hemin (0. 1 %) for 4 d. Following incubation, amoebae were incubated with NGPC 
( 1 :2). Each value represents the percent specific release of radiolabel ± standard 
error of the mean from amoebae from a representative experiment. 
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Figure 5: The effect of growth media alterations on susceptibility of Naegleria 
Jowleri to complement-mediated lysis. [3H]uridine-labeled N. Jowleri LEEmpC1 
were grown in Nelson or  Cline medium for a minimum of  20 d .  Parallel cultures 
of amoebae grown in Nelson medium were shifted to growth in Cline medium for 
2 h or 4 h followed by incubation with NGPC ( 1 :2). Each value represents the 
percent specific release of radiolabel ± standard error of the mean from amoebae 
from a representative experiment. 
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amoebae to become resistant to complement-mediated lysis following a shift to 
growth in Cline medium (Figure 6) .  Cycloheximide-treated control amoebae 
incubated in NHS demonstrated similar susceptibility to complement lysis when 
compared to untreated control amoebae incubated in NHS (data not shown). 
Metabolic-labeling of amoebae with Tran[35S]label (methionine:cysteine) 
was used to identify proteins differentially expressed in N. Jowleri following a shift 
from growth in Nelson medium to growth in Cline medium. Amoebae maintained 
in Nelson medium were shifted to growth in Cline medium in the presence of 
[35S]methionine:cysteine radiolabel for 2 hr. Lysates were generated and the 
radiolabeled proteins separated by SDS-PAGE. The gels were dried and 
subjected to autoradiography. Analysis of [35S]-labeled polypeptides using a 
Shimadzu image analyzer and computer integration programs allowed for the 
identification of polypeptides of approximate molecular mass 95, 65, 62, 50, 49, 44, 
and 28 kDa whose synthesis was induced in pathogenic N. Jowleri LEEmpCl in 
response to a shift in growth from Nelson medium to Cline medium (Figure 7). 
Polypeptides induced by shifts in media (lane 2) are indicated by arrows and the 
bands numbered consecutively from 1 (top) to 6 (bottom). Polypeptides 
synthesized by amoebae in response to a shift from Nelson to Cline medium were 
absent from lysates generated from a 2 h [35S]-labeling of LEEmpCl amoebae 
maintained throughout the experimental procedure in Nelson medium only. Table 
4 lists the relative molecular mass and density volume units corresponding to 
polypeptides detected following media alterations. Relative density volume values 
have been standardized to background density values. The densities of the 
57 
Figure 6 :  The effect of growth media alterations in the presence and absence of 
cycloheximide on susceptibility of Naegleria fowleri to complement-mediated lysis. 
N. fowleri LEEmpC1 grown in either Nelson medium or Cline medium for a 
minimum of 20 days were radiolabeled with [3H]uridine for 24 h. Radiolabeled 
amoebae were grown in medium in the presence or absence of 5J,Lg/ml 
cycloheximide (CHX) for 4 h prior to incubation with NGPC ( 1 :2) . Each value 
represents the percent specific release of radiolabel ± standard error of the mean 
from amoebae from a representative experiment. 
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Figure 7: Autoradiographic analysis of Tran[35S]methionine:cysteine-labeled 
Naegleria Jowleri LEEmpC1 subjected to media alteration. N. Jowleri LEEmpC 1  
were grown in Nelson or Cline medium for a minimum of 20 days. Amoebae 
were radiolabeled with Tran[35S]label (methionine:cysteine) for 2 h. A parallel 
culture of N. Jowleri grown in Nelson medium was shifted to growth in Cline 
medium for 2 h in the presence of Tran[35S]label. Whole cell lysates from N. 
Jowleri grown continuously in either Cline or Nelson medium or N. Jowleri 
subjected to a media shift were prepared and subjected to SDS-PAGE. The gels 
were dried and exposed to film for 14 days at -70·C. Lanes: ( 1) LEEmpC1 
amoebae grown in Nelson medium; (2) LEEmpC1 amoebae shifted from growth 
in Nelson medium to growth in Cline medium for 2 h; (3) LEEmpC1 amoebae 
grown in Cline medium. Arrows (lane 2) indicate proteins induced following a 
shift from growth in Nelson medium to growth in Cline medium (numbered 1-6) .  
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Table 4 :  Densitometric analysis of Naegleria Jowleri polypeptides expressed 
following alterations in amoebic growth mediuma• 
Band # 
1 
2 
3 
4 
5 
6 
Relative mol. 
mass 
95 kDa 
65 kDa 
62 kDa 
49 & 50 kDa (doublet) 
44 kDa 
28 kDa 
Relative density % Control 
units expressionb 
7.3 3 16 % 
9.8 50 % 
5.7 78 % 
3.9 79 % 
5.6 64 % 
13.7 84 % 
a N  Jowleri LEEmpC1 amoebae grown in Nelson medium were shifted to growth 
in Cline medium for 2 h at 37°C in the presence of Tran[35S]label. Amoebic 
lysates were generated and separated by SDS-PAGE. Gels were dried and 
subjected to autoradiography. Polypeptides detected by autoradiography were 
analyzed and compared using a Shimadzu scanner and integration programs. 
b Percent control expression was determined by comparing the relative densities 
of polypeptides induced in N Jowleri amoebae following a shift in growth from 
Nelson medium to Cline medium (Figure 6, lane 2) with the relative densities of 
the same polypeptides synthesized in amoebae grown in Cline medium (Figure 6, 
lane 3). 
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polypeptides (lane 2) were compared to the densities of the corresponding 
(control) polypeptides from amoebae grown in Cline medium (lane 3) and the 
percent of control expression was calculated. 
Protein analysis studies 
Three strains of Naegleria amoebae grown in Cline medium were treated 
with either phosphatidylinositol-specific phospholipase C (PIPLC) or 
endoglycosidase H (endo H). An in vitro lytic assay was used to confirm that 
enzymatic removal of surface-associated membrane components from 
complement-resistant amoebae enhanced their susceptibility to complement­
mediated lysis. Treatment of complement-resistant N. fowleri LEEmpCl  with 
PIPLC or endo H increased the susceptibility of highly-pathogenic amoebae to 
lysis by complement. In contrast, neither enzymatic treatment had a significant 
effect on the susceptibility of weakly pathogenic or nonpathogenic Naegleria 
amoebae to the lytic effects of complement (Figure 8). 
To assess the role of glycoproteins in resistance of N. fowleri to 
complement-mediated lysis, Naegleria amoebae were grown in Cline medium 
containing various concentrations of tunicamycin for 18 h prior to the addition of 
NGPC. The susceptibility of highly-pathogenic and weakly-pathogenic N. fowleri 
to lysis by complement increased in a dose-related manner following growth in 
medium containing 2.0 or 3.0 J.£g/ml tunicamycin (Figure 9). In contrast, growth 
of complement-sensitive, nonpathogenic N. gruberi amoebae in the presence of 
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Figure 8 :  The effect of enzymatic treatment on lysis of Naegleria amoebae by 
complement. [3H]uridine-Iabeled Naegleria amoebae (1  x lOS to 1 x 106) were 
treated with 500mU jrnl of PIPLC for 1 h or 40mU of endoglycosidase H for 4 h 
at 37°C. Following enzymatic treatment, amoebae were washed in HBSS and 
incubated in NGPC ( 1 :2) for 1 h at 37°C. Values represent the percent specific 
release of radiolabel ± standard error of the mean from a representative 
experiment. Asterisks denote statistically significant differences (p( 0.05 for 
PIPLC; P ( 0.2 for Endo H). 
A 100 
• None 
80 � PIPLC 
60 
40 
20 
o 
B 100 
80 
.� 60 
fI) 
� 
� 
� 40 
20 
o 
LEEmpCl 
• None 
� Endo H 
LEEmpC l 
LEE 
Amoebae 
LEE 
Amoebae 
64 
E G B  
E G B  
65 
Figure 9 :  The effect of tunicamycin on the susceptibility of Naegleria amoebae to 
complement-mediated lysis. [3H]uridine-labeled Naegleria spp. were grown in 
Cline medium the presence of 2J.Lg/ml or 3J.Lg/ml of tunicamycin for 18 hours at 
37°C (N. Jowleri) or at 30°C (N. gruberi). Tunicamycin-treated Naegleria were 
washed with HBSS followed by incubation in NGPC ( 1 :2) for 1 h at 37°C. Values 
represent the percent specific release of radiolabel ± standard error of the mean 
from a representative experiment. Asterisks denote statistically significant 
differences (p ( 0.01 for 2J.Lg/ml tunicamycin; p ( 0.001 for 3J.Lg/ml tunicamycin) . 
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tunicamycin did not alter the susceptibility of the amoebae to complement­
mediated lysis. To ensure that tunicamycin was not inhibiting protein synthesis, 
Naegleria spp. were radiolabeled with [35S]methionine in the presence or absence 
of tunicamycin. Inhibition of protein synthesis was determined by comparing the 
amount of [35S]methionine incorporated into tunicamycin-treated amoebae to the 
amount incorporated into untreated control amoebae. Treatment of amoebae 
with concentrations of 2J..£g/ml or 3J..£g/ml of tunicamycin for 18 h resulted in less 
than 6% inhibition of protein synthesis in N. Jowleri LEEmpC1 or LEE amoebae 
when compared to untreated control amoebae. Treatment of N. Jowleri amoebae 
with higher concentrations (4J..£g/ml) of tunicamycin or increased incubation 
periods with the drug, inhibited protein synthesis by 24%. In comparison, 
nonpathogenic N. gruberi amoebae were more sensitive to tunicamycin treatment. 
A minimal inhibition of protein synthesis ( 13%) occurred in the presence of 
3J..£g/ml of the drug. Higher concentrations of tunicamycin were found to be toxic 
to nonpathogenic Naegleria amoebae. 
To determine whether the effect of tunicamycin is reversible, [3H]uridine­
labeled amoebae were treated with tunicamycin for 18 h followed by incubation 
in tunicamycin-free medium for 24 h. Removal of tunicamycin from LEEmpC1  
and LEE amoebae and growth in tunicamycin-free medium for 24 h resulted in 
recovery from drug treatment with an increased ability to resist complement­
mediated damage when compared to the untreated control amoebae (Figure 10). 
Treatment with tunicamycin and removal of the drug had no effect on the 
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Figure 10: The effect of tunicamycin treatment followed by removal of the drug 
on the susceptibility of Naegleria amoebae to complement-mediated lysis. 
[3H]uridine-Iabeled Naegleria spp. were grown in the presence of 3J..1.g/ml of 
tunicamycin for 18 hours at 37°C (N. Jowleri) or 30°C (N. gruberi). Parallel 
cultures were treated with 3J..1.g/ml tunicamycin for 18 h followed by removal of 
drug and incubation in tunicamycin-free medium for an additional 24 h prior to 
assay. Following treatment amoebae were incubated with NGPC ( 1 :2) for 1 h at 
37°C. Values represent the percent specific release of radiolabel ± standard error 
of the mean from a representative experiment. Asterisks denote statistically 
significant differences (p < 0.01  for LEEmpCl ;  p < 0.001 for LEE). 
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susceptibility of nonpathogenic N. gruberi amoebae to complement. 
To examine the effect of tunicamycin treatment on protein expression in 
pathogenic and nonpathogenic amoebae, we employed [35S]methionine metabolic 
labeling. Amoebae were radiolabeled in either the presence or absence of 3}.£g/ml 
of tunicamycin. Cell lysates were prepared and analyzed using SDS-PAGE and 
autoradiography. The autoradiograms of both strains ofN. Jowleri (LEEmpC1  and 
LEE) amoebae treated with tunicamycin in the presence of [35S]methionine 
demonstrated an increase in the quantity or concentration of de novo synthesized 
proteins following tunicamycin treatment when compared to untreated control 
amoebae (Figure 1 1  A and 1 1  B). In contrast, an increased concentration of de 
novo synthesized proteins was not detected in nonpathogenic N. gruberi amoebae 
treated with tunicamycin (Figure 1 1C). In addition to an accumulation of proteins 
within the amoebae, the synthesis of several glycoproteins in pathogenic 
LEEmpC1 and LEE amoebae with relative molecular mass ranging from 18 kDa 
to 73 kDa were decreased or altered following tunicamycin treatment (Figure 1 1) .  
In particular, proteins of relative molecular mass 182, 50, 39, 34, 32, 30, and 29 
kDa were decreased or altered in both LEEmpC1 and LEE amoebae. 
Autoradiograms of iodinated amoeba surface proteins from the highly­
pathogenic N. Jowleri LEEmpC1 and weakly-pathogenic LEE detected proteins of 
similar molecular mass between the two strains. Proteins of molecular mass 89, 
60, 44, and 28 kD were identified in greater quantity in highly-pathogenic 
LEEmpC1 strain of N. Jowleri (Figure 12). These proteins were either absent or 
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Figure 1 1 :  The effect of tunicamycin on newly synthesized Naegleria-specific 
proteins. Autoradiographs of SDS-PAGE gels containing 25 IJ.g [35S]methionine­
labeled proteins of (A) N. Jowleri LEEmpCl ;  (B) N. Jowleri LEE; and (C) N. 
gruberi EGB amoebae were incubated in either the presence ( + ) or absence (-) of 
3lJ.g/ml of tunicamycin for 18 h at 37"C or 30"C. Arrows indicate proteins 
showing altered expression following tunicamycin treatment. 
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detected to a lesser extent by surface iodination in the weakly-pathogenic LEE 
strain. Few similarities in surface iodinated proteins were detected between 
pathogenic and nonpathogenic amoebae. Trypan blue exclusion in conjunction 
with phase contrast microscopy were used to determine whether amoebae were 
viable after iodination. Greater than 93% of the amoebae were viable as 
determined by the exclusion of dye. 
To further characterize the specific nature of these surface proteins, lysates 
from surface iodinated amoebae were separated by SDS-PAGE, transferred to 
nitrocellulose and stained using biotinylated lectins specific for either mannose 
(Concanavalin A) or fucose (Ulex europaeus agglutinin I). A comparison of 
duplicate immunoblots stained with the two lectins indicated that Naegleria 
proteins stain more intensely with Concanavalin A (Con A) as compared to 
staining with Ulex europaeus agglutinin I (Figure 13). Although, Con A recognized 
a number of glycoproteins in nonpathogenic N. gruberi amoebae, the molecular 
mass of these glycoproteins differed from the glycoproteins recognized by Con A 
in pathogenic strains of N. Jowleri. Autoradiograms of the lectin-stained 
irnmunoblots indicate that the four proteins identified in highly-pathogenic 
LEEmpCl amoebae by surface iodination were glycoproteins and possessed 
differences in the types of sugar residues associated with the proteins. The 89 
kDa surface protein was recognized by Con A, suggesting that mannose residues 
were associated with this protein. Surface proteins of molecular mass 60 and 28 
kDa stained with Ulex europaeus agglutinin I, suggesting the presence of fucose 
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Figure 12: Autoradiographic patterns of 125I-Iabeled cell surface proteins of 
pathogenic and nonpathogenic Naegleria spp. separated by SDS-PAGE. Iodinated 
cell surface proteins of N. Jowleri LEEmpC1, N. Jowleri LEE and N. gruberi EGB 
amoebae were separated by SDS-PAGE and bands identified by Coomassie blue 
staining (A) . Gels were dried and exposed to film for 28 h (B). LEEmpC1 
amoebae (lane 1) ;  LEE amoebae (lane 2) ; EGB amoebae (lane 3).  Arrows 
indicate protein differences between LEEmpC1 and LEE amoebae. 
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Figure 13:  Biotinylated lectin stain of lysates from surface iodinated Naegleria spp. 
Lysates of surface iodinated amoebae were separated by SDS-PAGE, transferred 
to nitrocellulose and bands identified using (A) biotinylated Concanavalin A or 
(B) biotinylated Ulex europaeus agglutinin I. LEEmpC1 amoebae (lane 1 ) ;  LEE 
amoebae (lane 2) ; EGB amoebae (lane 3) .  Arrows indicate lectin staining of bands 
corresponding to surface iodinated proteins identified in highly-pathogenic 
LEEmpC1 amoebae. 
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residues. The 44 kDa polypeptide was recognized by both Con A and Ulex 
europaeus agglutinin I suggesting that both sugar residues were present on this 
polypeptide. Arrows indicate the bands stained by each lectin which correspond 
to the bands present in greater quantity in highly-pathogenic LEEmpCl amoebae 
as detected by surface iodination. 
CD59 studies 
Polyclonal antiserum to CD59 from human erythrocytes was used to 
identify proteins in N. Jowleri amoebae which cross-react with antiserum to this 
human complement regulatory protein. Whole cell lysates from complement­
resistant N. Jowleri, complement-sensitive N. gruberi and red blood cells (RBC) 
were separated by SDS-PAGE under nonreducing conditions and the proteins 
transferred to nitrocellulose membranes. Antiserum to CD59 recognized 
polypeptides of approximate molecular mass of 54, 46 and 42 kDa on 
complement-resistant amoebae (Figure 14, lanes 1 & 2) which were not identified 
on complement-sensitive N. gruberi amoebae (Figure 14, lane 3) . Reactivity of 
anti-CD59 with human RBC lysates was used as a positive control for expression 
of the CD59, 18-20 kDa protein species (Figure 14, lane 4).  
Immunofluorescence microscopy of pathogenic and nonpathogenic Naegleria 
stained with polyclonal antiserum against CD59 and FITC-conjugated goat anti­
rabbit IgG demonstrated that pathogenic N. Jowleri stain positive for the presence 
of CD59 and that fluorescence was localized to specific sites on the surface of the 
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Figure 14: Western immunoblot analysis of proteins from Naegleria spp. stained 
with antiserum to human CD59. Whole cell lysates from highly-pathogenic, N. 
Jowleri LEEmpC1 (lane 1), weakly-pathogenic LEE (lane 2) and nonpathogenic 
N. gruberi (lane 3) amoebae were separated by SDS-PAGE under non-reducing 
conditions. Proteins were transferred to nitrocellulose membranes and stained 
using antiserum to human CD59 and peroxidase conjugated goat anti-rabbit 
antiserum. Lysates from human RBC ghosts were prepared and used as the 
positive control (lane 4). N. Jowleri reactive proteins denoted by solid arrows. 
Open arrow ( >  ) indicates CD59 cross-reactive protein in human RBC. 
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amoebae (Figure 15 B). A similar staining pattern was visualized with weakly­
pathogenic N. Jowleri LEE stained with anti-CD59 (data not shown). In contrast, 
immunofluorescence staining of nonpathogenic N. gruberi amoebae with anti-CD59 
did not detect a significant amount of fluorescence staining above background 
(Figure 15 D). CD59-specific staining intensity was shown to increase when the 
amoebae were treated with NHS prior to membrane fIxation and staining (data 
not shown). Minimal background staining was observed when amoebae were 
incubated with FITC-conjugated goat anti-rabbit IgG alone (Figure 15 A and C). 
Immunoprecipitation analysis was performed to determine whether the 
CD59 cross-reacting polypeptides detected by western immunoblot analysis were 
synthesized by N. Jowleri amoebae. Proteins from pathogenic and nonpathogenic 
Naegleria amoebae were metabolically labeled with Tran[35S]-methionine:cysteine. 
Radiolabeled lysates were incubated with antiserum to CD59. Cross-reacting 
antigens were immunoprecipitated using protein A sepharose beads, subjected to 
non-reducing SDS-PAGE and analyzed by autoradiography. Immunoprecipitation 
detected a 46 kDa protein species in highly-pathogenic and weakly-pathogenic N. 
fowleri amoebae (Figure 16, lanes 1 & 2). This protein was not detected in in 
nonpathogenic N. gruberi amoebae (Figure 16, lane 3).  
The susceptibility of pathogenic and nonpathogenic Naegleria to 
complement-mediated lysis in the presence of membrane-bound antibody to 
human CD59 was performed to determine whether CD59 antibody was capable 
of increasing the susceptibility of complement-resistant N. Jowleri to complement 
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Figure 15:  Immunofluorescence microscopy of Naegleria amoebae stained with 
polyclonal antiserum to human CD59. Pathogenic (A & B) and nonpathogenic 
(C & D) Naegleria amoebae were adhered to coverglasses and incubated in the 
presence or absence of NHS followed by fixation with 0.25% paraformaldehyde 
for 2 h at 37°C. Coverslips were stained with polyclonal antiserum to CD59 
followed by FITC-labeled goat anti-rabbit IgG antiserum and visualized by 
immunofluorescence microscopy. Left panels (A & C) were stained with FITC­
labeled goat anti-rabbit IgG antiserum only. Right panels (B & D) were stained 
with rabbit anti-CD59 and FITC-Iabeled antiserum. 
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Figure 16: Immunoprecipitation analysis of pathogenic and nonpathogenic 
Naegleria using antiserum to human CD59. Naegleria amoebae were radiolabeled 
with TranesS]label (methionine: cysteine ) for 24 h. Whole cell lysates were 
generated and incubated with 25J,Lg of polyclonal antiserum to human CD59 for 
18 h at 40 C. Antigen-antibody complexes were isolated with protein A-sepharose 
beads. Immunoprecipitated proteins were separated by SDS-PAGE undernon­
reducing conditions, the gels dried and subjected to autoradiography. Lanes ( 1 )  
Highly-pathogenic N. fowleri LEEmpCl, (2) Weakly-pathogenic N. fowleri LEE, 
(3) Nonpathogenic N. gruberi amoebae. 
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lysis. The binding of anti-CD59 to the surface of complement-resistant amoebae 
resulted in a modest increase in susceptibility of N. towleri to complement lysis 
(Figure 17 A). Anti-CD59 treatment of nonpathogenic, complement-sensitive N. 
gruberi amoebae did not alter susceptibility to complement lysis (data not shown). 
Polyclonal mouse antiserum generated to CD59 cross-reacting N. lowleri proteins 
were used to determine whether antiserum to N. lowleri proteins resulted in a 
greater increase in susceptibility of complement-resistant amoebae to complement 
lysis. The binding of antiserum to the 46 kDa polypeptide to N. lowleri amoebae 
increased the susceptibility of the amoebae to complement, however the increase 
was similar to that seen with anti-CD59 antiserum (Figure 17 B).  
Northern analysis revealed the presence of an approximate 2000 bp RNA 
species which hybridized to the CD59 probe in only pathogenic, complement­
resistant N. lowleri amoebae (Figure 18, lanes 2 & 3) .  Only background 
hybridization was detected in RNA from nonpathogenic, complement-sensitive N. 
gruberi amoebae (Figure 18, lane 1) .  Overexposure of northern blots revealed and 
additional RNA species of approximately 900 bp (data not shown). Hybridization 
of the same membrane with the GPD probe verified equivalent RNA loading in 
each lane. Northern membranes were subjected to BetaGen scanner analysis to 
quantitiate and compare the relative amounts of probe-bound radioactivity 
associated with the RNA. The amount of radioactive CD59 probe which 
hybridized to RNA from pathogenic, complement resistant N. lowleri was 
significantly greater than the background hybridization detected from 
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Figure 17: Effect of membrane bound antibody on susceptibility of highly­
pathogenic N. Jowlen to complement-mediated lysis. [3]H-uridine labeled N. 
Jowlen were incubated in the presence of HBSS or polyclonal antiserum to CD59 
(A) or GP46 (B) for 1 h at 4 C. Susceptibility to complement was measured by 
incubation in NHS for 1 h at 37°C. Each value represents the percent specific 
release of radiolabel ± standard error of the mean from amoebae from a 
representative experiment. 
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Figure 18: Northern blot analysis of CD59 expression. Total RNA (5J.1.g) from 
pathogenic and nonpathogenic Naegleria amoebae was separated by agarose gel 
electrophoresis, transferred to nitrocellulose membranes and hybridized with 
either a CD59 cDNA probe from the K562 cell line or a glyceraldehyde 3-
phosphate dehydrogenase (GPD) cDNA probe. Position of the 28S and 18S 
ribosomal bands are indicated. Lanes (1)  Nonpathogenic, complement-sensitive 
N. gruberi, (2) Weakly-pathogenic N. Jowleri LEE, (3) Highly-pathogenic, 
complement-resistant N. Jowleri LEEmpCl .  
CD59 probe 
1 2 
GPD probe 
1 2 
3 
3 
28S 
18S 
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nonpathogenic, complement-sensitive N. gruberi amoebae. 
Vesiculation studies 
Nomarski optics microscopy was used to visualize pathogenic, complement-
resistant N. Jowleri in the presence of NHS. Following a 15 min incubation in 
serum complement, highly-pathogenic N. Jowleri change shape from amoeboid to 
round with the formation of membrane blebs on the amoeba surface (Figure 19 
A). After a 60 min incubation in serum complement, an increase in the number 
of membrane blebs associated with the surface of the amoebae was observed 
(Figure 19 B). Membrane blebbing was not detected on the surface of 
complement-sensitive, nonpathogenic N. gruberi after incubation in NHS. Neither 
complement-resistant N. Jowleri nor complement-sensitive N. gruberi exhibited 
membrane blebbing when incubated with HBSS alone (data not shown). 
Scanning and transmission electron microscopy allowed for a closer analysis 
of the amoeba surface following incubation in NHS. Transmission electron 
micrographs illustrate structures which appear to represent distinct membrane 
extensions (vesicles) on the surface of the amoebae (Figure 20 A). These 
membrane vesicles do not appear to contain cellular organelles such as 
mitochondria. Cellular organelles appear to reorganize within the cytoplasm of 
the amoebae away from the forming membrane vesicle. NHS-treated amoebae 
were processed for SEM. Scanning electron microscopy detected a significantly 
larger number of membrane blebs on the amoebae in response to NHS treatment 
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Figure 19:  Nomarski optics microscopy of complement-resistant N. fowleri 
amoebae incubated in normal human serum for 15 min (A) or 60 min (B). N. 
fowleri LEEmpCl amoebae were incubated with NHS followed by fixation with 
2.5% glutaraldehyde at 37°C. Arrows indicate membrane blebs or vesicles 
detected by Nomarski optics microscopy. 
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Figure 20: Transmission and scanning electron microscopy of N. Jowleri amoebae 
incubated in NHS. Highly-pathogenic, complement-resistant N. Jowleri LEEmpC1 
amoebae were incubated in NHS diluted 1 :8  followed by 2.5% glutaraldehyde 
fixation at 37·C in 0. 1 M cacodylate buffer pH 7.2. Fixed amoebae were 
processed for either transmission (A) or scanning (B) electron microscopy. 
Arrows indicate membrane vesicles formed in response to incubation in low 
concentrations of serum complement. 
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as compared to the membrane blebs detected by nomarski optics microscopy 
(Figure 20 B). SEM of complement-resistant N. lowlen treated with different 
concentrations of NHS demonstrated that membrane vesiculation was more 
prominent when amoebae were incubated with NHS diluted 1 :8  (Figure 21 C & 
D). N. fowleri amoebae incubated in serum diluted 1 :2 showed less vesiculation 
in comparison (Figures 21 A & B). 
Binding assays were performed to determine whether highly-pathogenic N. 
lowlen amoebae specifically bound complement component, C9, the final protein 
required for MAC formation. Incubation of highly-pathogenic LEEmpCl with 
NHS e25I-C9) resulted in a 2.7% specific binding of 125I-C9 to the amoebae or 
approximately 2 x 106 molecules of C9 per amoeba. The specific binding was 
quantitatively determined to be in excess of nonspecific 125I_C9 binding which 
occurred in the presence of a 50-fold excess of cold C9 protein. 
Due to the binding of C9 and formation of the MAC on the surface of 
highly-pathogenic amoebae, indirect immunofluorescent staining was employed to 
determine the location of the bound complement proteins (C5b-C9) and to 
determine whether membrane attack complexes were present on the membrane 
blebs. Polyclonal rabbit antiserum specific for the detection of human 
complement proteins (C5b-C9) comprising the intact MAC (anti-MAC) was used 
in combination with FITC-conjugated goat anti-rabbit Ig and fluorescence 
microscopy to visualize the location of the MAC. Pathogenic, complement­
resistant amoebae stained positive for the presence of the MAC following a 15 
min incubation in diluted NHS. Positive fluorescent staining was concentrated at 
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Figure 21 :  Scanning electron microscopy of N. fowleri amoebae incubated in 
different concentrations of NHS. Highly-pathogenic, complement-resistant N. 
Jowlen amoebae were incubated in NHS diluted 1 :2 (A & C) or 1 :8  (B & D) for 
30 min followed by 2.5% glutaraldehyde fixation. Arrows indicate membrane 
vesicles in response to incubation in serum complement. 
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the membrane surface of the amoebae confirming that membrane attack 
complexes were present on the surface of the amoebae following initial exposure 
to NHS diluted 1 :4 (Figure 22 A). In addition, a significant increase in the 
intensity of fluorescent staining of the membrane blebs was observed when 
amoebae were incubated for 60 min in NHS diluted 1 :4 (Figure 22 B). The 
formation of large membrane vesicles or blebs was observed when N. [owleri were 
incubated in the presence of less concentrated NHS ( 1 : 16) (Figure 22 C & D) or 
1:8 (Figure 22 E & F). The appearance of membrane blebs was paralleled by a 
shift in staining intensity from a diffuse halo-like staining of the entire plasma 
membrane to a localized staining of large membrane blebs. Nomarski optics 
microscopy of the same sample confirmed that the fluorescent staining 
corresponded to the presence of membrane blebs on the surface of the amoeba 
(Figure 22 D & F). 
Differential centrifugation was combined with radioiodinated C9 binding 
studies to separate intact amoebae from released membrane vesicles in order to 
quantitate the kinetics of binding and release of the MAC (C5b-12SI-C9) to 
complement-resistant amoebae. Following initial exposure ( 15 min) of N. [owleri 
to NHS containing 12SI_C9, 99.3% of the membrane-bound 12SI_C9 cpm was 
associated with pellet 1 which consisted of predominately intact amoebae, whereas 
0.7% of the membrane-bound cpm was associated with pellet 2 containing 
predominately released membrane vesicles (Figure 23) .  Following incubation of 
amoebae with NHS for 30, 90, and 120 min, a time-dependent decrease in 
membrane-bound cpm detected in pellet 1 (amoebae) was paralleled with an 
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Figure 22: Detection of the membrane attack complex (MAC) on the membrane 
and membrane vesicles of highly-pathogenic N. Jowlen amoebae incubated with 
NHS. Immunofluorescence microscopy of N. Jowlen amoebae incubated with NHS 
diluted 1 :4 for 15 min (A) ; or 60 min (B) and stained with polyclonal rabbit 
antiserum to human MAC proteins (anti-MAC) followed by FITC-Iabeled goat 
anti-rabbit IgG antiserum. N. Jowlen amoebae incubated with NHS diluted 1 :  16  
(C) or  1 :8  (E) for 30 min and stained with polyclonal anti-MAC antiserum and 
FITC goat anti-rabbit IgG and visualized by immunofluorescence microscopy and 
N omarski optics microscopy (D & F). 
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Figure 23 : Binding of 125I_C9 labeled normal human serum to N. towleri and 
release in the form of membrane vesicles. N. towleri LEEmEC1 amoebae ( 1  x 106) were incubated with C9-deficient NHS reconstituted with 25I-C9 for 15- 120 min. 
Spontaneous binding was determined by incubating amoebae in heat-inactivated 
NHS (iNHS) (50°C for 20 min) reconstituted with 125I_C9. Following incubation, 
the mixture was centrifuged at 1000 x g for 10 sec to pellet intact amoebae (pellet 
1). The supernatant was removed and centrifuged at 6000 x g for 20 min to pellet 
released membrane vesicles (pellet 2). The counts per minute (cpm) in each 
pellet and the percent C9 bound were determined. Error bars denote mean ± 
S.D. (n = 3) from a representative experiment. The asterisk denotes statistically 
significant difference in percent C9 bound at 15 min as compared to 120 min (p 
< 0.01) .  
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increase in the membrane-bound cpm detected in pellet 2 (vesicles). 
To visually confirm the contents of the two pellets obtained by differential 
centrifugation (pellet 1 and pellet 2), pellets were fixed with glutaraldehyde and 
mounted on glass slides for Nomarski optics microscopy. Intact amoebae can 
easily be distinguished from membrane vesicles on the basis of size. Differential 
centrifugation allowed for the separation of these two populations (Figure 24 A). 
Visualization of pellet 1 by Nomarski optics confirmed the presence of 
predominately intact amoebae (Figure 24 B). Pellet 2 contained "released" 
membrane vesicles (Figure 24 C). Figure 24 D illustrates the cell-free supernatant 
fluid remaining following this procedure. In order to determine the fate of each 
of the pellets when incubation was continued in NHS, pellets were generated and 
the samples were viewed in the presence of NHS, in the absence of glutaraldehyde 
fixation. Intact amoebae were detectable in pellet 1 following prolonged exposure 
to NHS, 2-4 h post-incubation (data not shown). However, prolonged exposure 
of pellet 2 (membrane vesicles) to NHS for 2-4 h resulted in complete degradation 
of the membrane vesicles with cellular debris remaining as evidence of lysed 
vesicles (data not shown). 
To determine whether membrane blebbing is required for resistance of 
pathogenic amoebae to complement lysis, we employed drugs to specifically inhibit 
membrane blebbing. Treatment of pathogenic amoebae with 20J,£g/ml 
cytochalasin D or cytochalasin B for 2 h followed by incubation in NHS resulted 
in a significant increase in the susceptibility of the amoebae to complement 
mediated lysis as measured using the amoebicidal assay (Figure 25) .  Removal of 
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Figure 24 : Nomarski optics microscopy of serum-treated N. Jowleri amoebae and 
released membrane vesicles separated by differential centrifugation. N. Jowleri 
LEEmpC1 amoebae were incubated with NHS for 15- 120 min. Following 
incubation, the mixture was centrifuged at 1000 x g for 10 sec to pellet intact 
amoebae (pellet 1) .  The supernatant was removed and centrifuged at 6000 x g for 
20 min to pellet released membrane vesicles (pellet 2) . Pellets and supernatant 
fluid were fixed with glutaraldehyde at 37·C to give a final concentration of 2.5%. 
Samples were mounted on glass slides and viewed by Nomarski optics microscopy. 
(A) Amoebae and vesicles; (B) Pellet 1 containing intact amoebae following 
treatment with NHS; (C) Pellet 2 containing released membrane vesicles from 
complement-resistant amoebae; (D) cell-free supernatant fluid. 
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the drug prior to complement addition resulted in recovery of the amoebae 
fromdrug treatment with a concomitant return of the ability to resist complement 
lysis. In contrast, treatment of nonpathogenic, complement -sensitive amoebae with 
the same concentrations of cytochalasin D or cytochalasin B did not alter 
susceptibility of the amoebae to complement lysis. 
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Figure 25 : Effect of cytochalasin D or cytochalasin B treatment on susceptibility 
of Naeglena amoebae to complement-mediated lysis. N. Jowlen LEEmpC1 (highly­
pathogenic, complement-resistant) and N. gruben EGB (nonpathogenic, 
complement-sensitive) amoebae were treated with cytochalasin D (20l-'g/ml) or 
cytochalasin B for 2 h at 37°C followed by incubation in NHS ± cytochalasin D 
or cytochalasin B. Each value represents the percent specific release of radio label 
(% lysis). Error bars denote mean ± standard error of the mean from a 
representative experiment. Similar data were obtained each time the experiment 
was repeated. The asterisk denotes stastically significant differences (p < 0.001 
for cytochalasin D; p < 0.01 for cytochalasin B). 
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Discussion 
Naegleria Jowleri amoebae are complement-resistant and highly-virulent in 
mice [ 125] .  The ability of growth medium to modulate the virulence of pathogenic 
N. Jowleri and susceptibility to complement-mediated lysis provides a mechanism 
to correlate virulence and resistance to complement lysis. These studies 
demonstrate that axenic maintenance of highly-pathogenic, mouse-passaged N. 
Jowleri in Nelson medium, a medium which supports the growth of N. Jowleri, 
results in a rapid decline in virulence and a concomitant loss of the ability to resist 
complement lysis. Maintenance of highly-pathogenic, mouse-passaged amoebae 
in Cline medium, which contains supplemental bovine hemin and calf serum 
maintains virulence for a longer period of time when grown axenically and 
maintains resistance to complement-mediated lysis. These results confirm those 
of Wong et al. [ 129] who demonstrated that mice inoculated with amoebae 
maintained in Nelson medium showed a decrease in mortality and an increase in 
the average time to death. We have determined that at least one ingredient of 
Cline medium, bovine hemin, plays a role in modulating the susceptibility of 
pathogenic N. Jowleri amoebae to complement-mediated lysis. Iron or iron 
containing compounds are important nutrients for N. Jowleri in vivo and in vitro. 
1 10 
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Newsome and Wilhelm [82] have suggested that exogenous iron may serve as a 
means for controlling the proliferation of pathogenic Naegleria amoebae. In 
addition, the role of hemin in H4 [3] medium was evaluated and shown to be 
capable of replacing the need for supplemental serum for growth of Naegleria 
amoebae [4] . The role of hemin or iron-containing compounds in virulence 
remains to be determined. 
The increased resistance of highly-pathogenic amoebae grown in Cline 
medium is not due to a difference in activation of the complement cascade since 
amoebae grown in either Nelson or Cline medium activate the complement 
pathway equally well as determined by the AP-CHso units depleted from serum by 
the amoebae grown in either medium. Instead, differences in the susceptibility of 
N. Jowleri amoebae to complement lysis following axenic growth in different media 
may be due to media-induced differential gene expression or protein synthesis. 
Specific ingredients in Cline medium, such as hemin, may allow for the synthesis 
of proteins required for resistance to complement or may regulate gene expression 
required for complement resistance. To analyze whether amoebae maintained in 
different growth media express different proteins, protein profiles of N. Jowleri 
were examined by SDS PAGE and western immunoblot analysis. In these studies, 
growth medium was shown to have a major influence on the protein species 
synthesized by N. Jowleri amoebae. Protein profiles of highly-pathogenic N. Jowleri 
amoebae are more similar to weakly-pathogenic amoebae when both amoebae are 
grown in the same medium. However, protein differences observed may not 
reflect a change from a weakly-pathogenic to a highly-pathogenic state. Hu et al. 
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[40] studied protein synthesis patterns of highly-pathogenic and wealdy-pathognic 
N. fowleri amoebae by two-dimensional gel electrophoresis. Changes in proteins 
synthesized by axenically cultured or mouse-passaged N. fowleri amoebae were 
attributed to whether amoebae were fed bacterial cells, mammalian cells, or grown 
in axenic medium. Specific proteins associated with virulence and resistance of 
N. fowleri amoebae to complement have not been identified. Surface proteins 
which confer resistance to complement lysis have been proposed as possible 
virulence markers for highly-pathogenic N. fowleri LEEmpC1 amoebae [6 1 ,  1 19, 
126] . The inability of cycloheximide-treated N. fowleri grown in Nelson medium 
to become resistant to complement lysis when switched to growth in Cline medium 
corroborates the hypothesis that specific proteins are involved in the mechanism 
by which N. fowleri amoebae resist complement-mediated damage. These data 
indicate that the synthesis of specific proteins involved in protecting N. fowleri 
from complement-mediated damage may be regulated by specific constituents of 
growth media. 
Proteins induced during growth in different media can be detected with 
metabolic-labeling using 35S-methionine following a shift of the amoebae from 
growth in Nelson medium to growth in Cline medium. This method has allowed 
for the identification of a number of polypeptides which are uniquely synthesized 
by highly-pathogenic, complement-resistant amoebae when grown in Cline 
medium. Hu et al. [40] have identified a number of low molecular mass 
polypeptides whose synthesis was influenced in pathogenic N. fowleri amoebae 
following a transformation from a low-virulence to a high-virulence state. The 
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transformation from a low-virulence state to a high-virulence state was in response 
to growth on lawns of bacteria [40] . However, the specific proteins associated with 
virulence remain to be identified. 
Proteins from pathogenic and nonpathogenic Naegleria were subjected to 
biochemical analyses to identify and characterize specific proteins associated with 
virulence and complement-resistance. Previously, Whiteman and Marciano-Cabral 
[ 126] demonstrated that enzymatic removal of surface components from highly­
pathogenic N. fowleri amoebae increased the susceptibility of complement-resistant 
amoebae to complement-mediated lysis. Enzymatic treatment of nonpathogenic 
or weakly-pathogenic amoebae had no effect on complement-mediated lysis 
indicating that specific surface components of highly-pathogenic amoebae play a 
role in regulating complement-mediated lysis [ 126] . To determine whether the 
membrane components responsible for regulating complement-mediated lysis are 
glycosyl-phosphatidylinositol (GPI)-anchored proteins or glycoproteins in nature, 
enzymes with specific cleavage sites were utilized. Both PIPLC, which removes 
GPI-anchored proteins, and Endo H, which removes high mannose residues 
present on glycoproteins increased the susceptibility of resistant amoebae to 
complement-mediated lysis, but did not significantly effect complement-mediated 
lysis of weakly-pathogenic or nonpathogenic Naeg/eria amoebae. The increased 
susceptibility seen after PIPLC treatment of highly-pathogenic Naeg/eria suggests 
that N. fowleri amoebae possess a GPI-anchored protein on their surface 
membrane which may play a role in regulating the complement pathway. GPI­
anchored proteins which confer resistance to complement lysis include decay 
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accelerating factor [ 19, 70], homologous restriction factor IC8-binding protein [33] ,  
and CD59 [ 18, 88] . The slight increase in susceptibility of N. Jowleri amoebae to 
complement after PIPLC treatment may be due to the fact that many GPI­
anchored proteins are relatively resistant to PIPLC release [22, 57, 58] .  Weakly­
pathogenic amoebae may have the same proteins but to a lesser extent. Increased 
concentrations of PIPLC or prolonged treatment with the enzyme can overcome 
resistance of certain proteins to release by PIPLC. In the present study, high 
concentrations of PIPLC or increased treatment periods were found to be toxic 
to Naegleria amoebae (data not shown). 
A number of complement regulatory proteins are membrane-bound 
glycoproteins. To analyze the role of carbohydrate moieties present on membrane 
glycoproteins, we employed the use of endoglycosidase H, an enzyme which 
specifically cleaves N-linked high mannose residues of glycoproteins. Treatment 
of highly-pathogenic LEEmpCl amoebae with endoglycosidase H increased the 
susceptibility of these amoebae to complement lysis. Treatment of weakly­
pathogenic or nonpathogenic strains of Naegleria did not significantly alter 
susceptibility to complement-mediated lysis. These data indicate that the proteins 
involved in resistance to complement-mediated lysis are glycoproteins. Removal 
of N-linked carbohydrates may affect the ability of amoebae to resist lysis by 
either altering the conformation of specific proteins or by removing a functional 
portion of the protein which is required for inhibition of complement-mediated 
lysis. 
Tunicamycin, a naturally occurring antibiotic, specifically blocks the 
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formation of N-linked protein-carbohydrate linkages and allows for an analysis of 
the functional role for specific carbohydrates of glycoproteins. Heterogeneous 
preparations of tunicamycin can significantly inhibit protein synthesis in addition 
to inhibiting protein glycosylation at asparagine residues [60] . Tunicamycin 
treatment of Naeg/eria amoebae for 18 h at a concentration which inhibits 
glycosylation, but not protein synthesis, increased the susceptibility of both highly­
pathogenic and weakly-pathogenic amoebae to complement lysis, but had no effect 
on nonpathogenic, N. gruberi. These studies support the hypothesis that 
glycoproteins are important in the ability of pathogenic amoebae to resist 
complement-mediated damage. Increased susceptibility to complement lysis 
following tunicamycin treatment is reversible since the amoebae completely 
recover their ability to resist complement damage after removal of the drug and 
subsequent incubation in tunicamycin-free medium. A slight increase in the ability 
of drug-treated amoebae to resist complement-mediated damage is detected 
following removal of the drug. Analysis of de novo synthesized proteins in the 
presence of tunicamycin indicates an accumulation of proteins within the amoebae 
following an 18 h treatment with the drug. Carbohydrate residues present on 
proteins are known to dictate proper protein folding and configuration which are 
necessary signals for secretion [27] . Glycoproteins which lack carbohydrates may 
either aggregate in the endoplasmic reticulum with subsequent degradation while 
other proteins remain unaffected [34, 90] . Increased resistance to complement 
lysis following removal of the drug may suggest that tunicamycin-treatment results 
in the accumulation of proteins within the amoebae. Removal of tunicamycin 
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allows these proteins to become rapidly processed and shuttled to the surface of 
the amoebae resulting in a net increase in the concentration of proteins on the 
surface of the amoebae enabling the amoebae to more efficiently resist 
complement-mediated damage and lysis. 
Enzymatic treatment to remove surface components increased the 
susceptibility of highly-pathogenic amoebae to complement, whereas inhibition of 
protein glycosylation by tunicamycin increased susceptibility of both highly­
pathogenic and weakly-pathogenic strains of N. Jowleri. These results indicate that 
glycoproteins present on both strains may play a role in protecting the amoebae 
from complement, but resistance may be the result of a quantitative difference in 
the glycoproteins expressed on the surface of the different strains. Glycoproteins 
important in conferring resistance to complement lysis are absent from 
nonpathogenic amoebae. 
To compare surface proteins present on complement-resistant amoebae 
which may be involved in resistance to lysis, we employed surface iodination in 
combination with autoradiography. Four proteins were identified in highly­
pathogenic, complement resistant amoebae by this technique which were either 
absent or reduced in quantity in the weakly pathogenic LEE strain. Lectin 
staining of surface proteins determined that these unique proteins were 
glycoproteins in nature. The attachment of terminal sugars are a major source of 
structural diversity for N-linked glycoproteins. Mannose and fucose are known to 
be typical sugar residues associated with glycoproteins [90] . In the present study, 
lectins specific for the detection of mannose and fucose were used to differentiate 
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the carbohydrate residues associated with these surface proteins. Surface proteins 
detected in highly-pathogenic LEEmpC1 amoebae contain the carbohydrate 
residues, fucose and mannose. Few similarities in surface proteins were detected 
between pathogenic N. [owleri and nonpathogenic N. gruberi amoebae. 
The recognition of N. [owleri-specific polypeptides with antiserum to human 
CD59 suggests that these cross-reactive proteins may possess similar complement 
inhibitory function. Immunofluorescence microscopy using anti-CD59 localized 
the cross-reacting protein species to the surface of N. [owleri amoebae which is 
consistent with its location on RBCs. The ability of NHS to increase the surface 
expression of CD59 cross-reacting N. [owleri-polypeptides suggests that 
complement components may stimulate de novo synthesis of CD59. The ability 
of complement to enhance CD59 expression has been described [ 1 15] .  
Nonpathogenic N. gruberi amoebae do not appear to express significant levels of 
anti-CD59 cross-reacting polypeptides by western immunoblot analysis, 
immunoprecipitation, or immunofluorescence. The inability of Northern analysis 
to identify RNA species in nonpathogenic amoebae which hybridized to CD59 
cDNA further corroborates the hypothesis that nonpathogenic amoebae do not 
express a CD59-like protein. It has been reported that cDNA to CD59 hybridizes 
to four different species of message due to differences in polyadenylation [ 1 18, 
123] .  However, the inability of antiserum to CD59 or antiserum to polypeptides 
identified as unique to highly-pathogenic N. [owleri (46 kDa) to abrogate 
complement resistance could be due to the presence of more than one mechanism 
for regulating complement by the amoebae. 
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The membrane attack complex of the complement system is comprised of 
terminal complement components C5b through C9 which damage cell surface 
membranes by the formation of transmembrane channels or pores within the 
membrane, ultimately resulting in osmotic lysis of the cell [75, 80] . A number of 
microorganisms and eukaryotic cells have developed mechanisms to evade 
complement lysis. Regulatory proteins present on the surface of cells interfere by 
either preventing activation of the complement pathway or by preventing lysis of 
the cell once complement has been activated [46, 75] .  
In addition to  the presence of  cell surface proteins which inhibit the 
complement pathway, a variety of regulatory mechanisms have been identified 
which protect cells from damage by the MAC of complement. The mechanisms 
which have been described include the ability of cells to shed the MAC (C5b-C9) 
from the cell surface in the form of membrane blebs or vesicles (vesiculation), 
endocytosis and degradation of membrane-bound C5b-C9 and the inability of the 
MAC to become inserted into the cell membrane lipid bilayer due to steric 
hindrance [49, 76, 77] . Several investigators have shown that binding of 
complement proteins, C5b through C9 (MAC), induces the production and release 
of membrane vesicles from cells such as erythrocytes, platelets, and neutrophils 
and serves as a protective mechanism against complement-mediated damage [77. 
1 12] . 
Various microscopic techniques were employed to evaluate whether highly­
pathogenic, complement-resistant N. Jowleri amoebae possess an alternative 
mechanism for resisting complement lysis, in addition to complement regulatory 
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proteins. Nomarski optics microscopy demonstrated that incubation of bighly­
pathogenic, complement-resistant amoebae in NHS resulted in the formation of 
membrane blebs or vesicles in response to serum complement. Membrane 
vesicles associated with the entire surface of amoebae treated with NHS were 
observed using scanning electron microscopy. A greater number of membrane 
vesicles were detected on amoebae treated with a 1 :8  dilution of NHS when 
compared to amoebae treated with NHS diluted 1 :2. These data indicate that 
under conditions of low serum concentrations, complement-resistant Naegleria 
remove the MAC from their surface by vesiculation. Similarly, Morgan et al. 
( 1986ji) have demonstrated that the human histiocytic cell line, U937, escapes 
complement-mediated damage in the presence of low doses of C9, by the physical 
removal of C5b-C9 from the cell surface. Resistance of highly-pathogenic N. 
Jowleri to complement lysis when incubated in high concentrations of serum (ie. 
undiluted) may be due to the presence of complement regulatory proteins which 
serve as the predominate mechanism for complement regulation. Alternatively, 
membrane vesiculation and complement regulatory proteins may act in concert to 
allow highly-pathogenic N. Jowleri to escape complement damage. 
Using radioiodinated complement component, C9, the presence of C9 
binding to the amoeba surface was confirmed. Thus, the inability to form the 
membrane attack complex because of a lack of C9 binding was not a mechanism 
for complement resistance. 
To monitor the formation of the MAC on highly-pathogenic amoebae, an 
indirect immunofluorescence assay of N. Jowleri using anti-MAC antiserum was 
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performed. Immunofluorescence microscopy confirmed the presence of C5b 
through C9 on the surface of the amoebae with identification of the MAC 
associated with membrane blebs. Antiserum to the MAC was used to monitor the 
location of C5b-C9 at different time intervals following addition of NHS. The 
entire surface of the amoebae stained positive for the presence of the MAC 
confirming that complement-resistant amoebae are capable of binding the MAC 
and localizing the complexes to specific areas on the plasma membrane. The 
presence of membrane blebs indicates that the amoebae are capable of removing 
portions of their plasma membrane in response to damage by complement 
proteins. In addition, a shift in staining intensity from the plasma membrane to 
a concentrated staining of the membrane blebs indicates that the portions of 
amoeba membrane removed by vesiculation contain deposited membrane attack 
complexes. It has been proposed that specific proteins, in particular, GPI-linked 
proteins may play a role in triggering vesiculation of erythrocytes [ 128] . 
Erythrocytes from patients with paroxysmal nocturnal hemoglobinuria as well as 
mutant B-Iymphoblastoid cell lines, both lacking GPI-anchored proteins have an 
impaired ability to vesiculate in response to complement [ 128] . Membrane 
vesiculation by highly-pathogenic, complement-resistant N. Jowleri, also, may be 
triggered by cell surface proteins or by the interaction of the MAC with proteins . 
associated with the cell surface of the amoebae. 
To quantitate the kinetics of C5b-C9 (MAC) binding to the surface of 
complement resistant amoebae, l�I-C9 binding was combined with differential 
centrifugation in order to determine the amount of radioactivity associated with 
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intact amoebae or membrane vesicles. An increase in the amount of 125I_C9 
associated with the vesicle fraction was detected with increasing incubation in 
dilute NHS. This increase in vesicle-associated radioactivity corresponded to a 
decrease in the radioactivity associated with intact amoebae. In addition to 
removing the MAC, the released vesicles may serve as a decoy for the binding of 
additional complement components, preventing their binding to the amoebae. 
Visualization of the fraction containing membrane vesicles not treated with 
glutaraldehyde demonstrated complete destruction of the vesicles after prolonged 
incubation in serum complement. 
The ability of cytochalasin D or cytochalasin B treatment to block exocytic 
events such as vesiculation and to significantly increase the susceptibility of highly­
pathogenic N. Jowlen amoebae to complement lysis corroborates the importance 
of vesiculation as a mechanism by which the amoebae overcome complement 
damage. 
From this study, the following mechanism of complement resistance of 
highly-pathogenic N. Jowlen can be hypothesized (Figure 26). Incubation of N. 
Jowlen amoebae in the presence of low concentrations of serum complement 
results in ACP activation, and subsequent deposition of the MAC, C5b through 
C9, on the cell surface of the amoebae. Following MAC deposition, the amoebae 
rapidly localize the complexes in their plasma membrane and begin to form 
. membrane blebs containing the deposited complement proteins. The removal of 
these complexes occurs when the vesicles are exocytosed from the plasma 
membrane, a process termed vesiculation. The final fate of the released vesicles 
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is complete destruction by the remaining complement activity present in serum. 
The physical removal of the MAC from the cell surface of highly-pathogenic, 
complement-resistant amoebae serves as one a mechanism by which the amoebae 
protect themselves from complement-mediated lysis. In the presence of high 
concentrations of NHS, complement-resistant N. fowleri are protected from 
complement-mediated damage not only by their ability to remove surface 
associated MAC, but also by their ability to synthesize specific complement 
regulatory proteins such as a CD59-like glycoprotein. The combination of cell 
surface regulatory proteins and use of mechanisms such as membrane vesiculation, 
highly-pathogenic amoebae can resist lysis in high concentrations of serum 
complement. 
The fact that pathogenic Naegleria amoebae are capable of membrane 
vesiculation and the synthesis of proteins similar in function to CD59 is an 
important determinant of virulence for this organism. An understanding of these 
as well as other virulence mechanisms of pathogenic N. fowleri amoebae will help 
in targeting proper treatment regimens for primary amoebic meningoencephalitis. 
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Figure 26: Proposed mechanism of complement resistance by highly-pathogenic 
N. Jowleri LEEmpC1 amoebae. 
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